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ABSTRACT 
 
 
 The drug Sirupeelai (Aerva lanata) was selected to study its efficacy in the 
management of Neeradaippu. The biochemical analysis and XRF studies of the drug 
were done to found out the metals and minerals present in the herb. In pharmacological 
aspect the Nephroprotective activity of the drug in Gentamicin models was studied in 
Wistar albino rats. The rats in prophylactic group were treated with the decoction at the 
dose of 270 mg (5.4 ml) and 500 mg (10.0 ml) / kg. They showed significant reduction in 
the level of Blood urea and Serum creatinine, Histopathology also reveals protective 
effect on renal damage. These findings suggest that the drug possess Nephroprotective 
activity with minimal toxicity and could offer promising role in the management of renal 
damage caused by nephrotoxins like Gentamicin. 
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INTRODUCTION 
 
 
 
 Siddha medicine owes the origin to medicinal ideas and practices of a class of 
Tamil Sages called the Siddhars – “ perfected ” or “ holy immortals ” – who were, and 
are still, believed to have super human powers. They had firm faith in the “deathless”. 
physical body being in tune with spiritual immortal ‘soul’. Significantly one of the 
definitions of siddha medicine is conquest of death; ‘that which ensures preventive 
against mortality’. This statement is attributed to Thirumoolar, a revered siddhars whose 
treatise called Thirumanthiram has 3000 stanzas. 
 
 The science of siddha medicine, unlike other systems, is a complex system of 
science in as much as it had included in the works of medicine, alchemy, philosophy, 
yoga, varma etc, with a view to elevate them in the long run the level of spiritualism. 
 
 Siddha system of medicine is still today a living science. System which has 
survived through centuries cannot be condemned as unscientific as we are ignorant of its 
scientific basis. Past siddars were inventors of even preventive medicines. We may 
discover and explain with reference to modern terminology. 
 
 The siddha schools of thought fully recognizes the ninety six Thatwas and further 
add that the human body is composed of 72,000 blood vessels 13,000 nerves, 10 main 
arteries, 10 vital airs altogether in the form of a network, and it is owing to the 
derangement of three humors (Vazhi, Azhal & Iyyam) becomes liable to 4,448 diseases. 
 3
This is well explained in the following verses from Iswara’s Meignana Naadi 
 ãÄ ¦ÁØ Àò¾£Ã¡ Â¢ÃÁ¡õ¿¡Ê 
  Ó¨Éò¦¾ØóÐ Å¨Ä§À¡Ä ÓÊó¾§¾¡§¼ 
 §¸¡ÄÁ¡öô À¾¢ýãÅ¡ Â¢Ãõ¿ÃõÒ 
  §¸¡÷¨ÅÂ¡ö Ýúó¾¢ÕìÌõ ÜðÊüÌû§Ç 
 ¸¡ÄÁ¡õ ¿¡ÊÀòÐ Å¡Ô ÀòÐ 
  ¸¾¢ò¾¦¾øÄ¡ Óì§¸¡÷¨Åô À¨¸Â¢É¡§Ä 
 ¿¡Ä¿¡ Ä¡Â¢ÃòÐ ¿¡ëü§È¡Î 
  ¿Å¢ø ¿¡üÀò ¦¾ñ§½¡Â¡ö ¿¡ð¼Ä¡§Á. 
 
 The 3 humors in their normal order occupy lower, middle and upper parts of the 
body respectively. Azhal humor occupies the regions of stomach and internal visceras. 
This is mentioned in Siddha literatures as, 
 ¯ó¾¢ Å¢Â÷¨Å ¯¾¢ÃÁ¢Ãô¨À¸ñ 
  ºó¾¢Ã ¦ÅñÓ¸ò¾¡ö º¡ü¦È¡û- ¾ó¾¢Î§¾¡ø 
 ¦¿öò¾ ¿¢½ ¿£÷ÅÇ÷îº¢ ¿øÌ Á¢Ãº¾¡ 
  ¦¾öò¾¢¼¡ À¢ò¾ò¾¢¼õ. 
     (Á. ¾. À¡) 
 §À¡¦ÁýÈ À¢ò¾òÐì ¸¢ÕôÀ¢¼§Á §¸Ç¡ö 
  §ÀÃ¡É ¸ñ¼ò¾¢ý ¸£Æ ¾¡Ìõ. 
  
 In scientific parlance, Azhal humor has the functions of thermogenesis, 
metabolism within its limits, the process of digestion, coloration of blood, excretion and 
secretion etc.  
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 According to Siddha literature, Neeradaippu is a condition due to vitiated Azhal 
humor. The pathology ( Mukuttra iyal) of Neeradaippu was described in Siddha literature 
as follows, the derangement of Azhal humor results in diminished urine output, 
accumulation of waste products in blood and debilitation of the patient. Then Iyya humor 
combines with deranged Azhal humor and cause generalized oedema and the associated 
symptoms like dyspnoea, peri orbital oedema, giddiness, fainting and vomiting. Finally 
Vazhi humor also combines with it and causes abdominal distension, abdominal pain, 
headache, chest pain and malaise. 
  
 All the above symptoms can be correlated with the symptoms of impaired renal 
function. The herb Sirupeelai (Aerva lanata) is considered as a remedy for Neeradaippu 
in Siddha literature like Agasthiar Gunavagadam. The suffering humanity has been 
benefited by Mother Nature through her gift of herbs, minerals and metals. In the text 
Bohar Nigandu 1200 the name of Sirupeelai is mentioned as Uppu chatthai nasamakki  
 
 This also gives an idea that this drug may remove the metabolic waste products 
from blood. These Siddha literary evidences drove the author to select the drug Sirupeelai 
for its nephroprotective action. 
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AIM AND OBJECTIVES 
 
 
AIM: 
 
 The aim of the dissertation is to evaluate the efficacy of Sirupeelai Kudineer in 
the management of Neeradaippu. 
 
OBJECTIVES: 
 
 In the medical field impairment of renal function is one of the challenging 
problem causing mortality and morbidity, for which there is no remedial measures in 
conventional medicine. There is a continuous search for agents which provide protection 
against the renal impairment caused by drugs. This fact drove the author to go for a 
native solution through Sirupeelai Kudineer. 
 
 Sirupeelai is the well known herb being used by many Siddha practitioners. The 
plant contains flavanoids such as Kaempferol 3-rhamnoside and Kaempferol 3 – 
galactoside which are well known potent antioxidant and free radical scavengers. The 
Siddha literature the name of Sirupeelai was mentioned as ‘Uppu chathai nasamakki’. 
This name also impresses the author to evaluate the Nephroprotective effect of the herb.  
 
The efficacy of Sirupeelai Kudineer has been evaluated in the following aspects, 
 Collection of literary evidences in siddha and botanical aspects 
 Biochemical analysis 
 XRF studies  
 Pharmacological studies. 
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GUNAPADAM ASPECT 
 
º¢ÚÀ£¨Ç 
 
 
§ÅÚ ¦ÀÂ÷¸û: 
 
 º¢Úâ¨Çô §À÷¾¨É§Â ¦ºôÀì§¸Ù 
               ¦ºÂÁ¡É À¡„¡½ô §À¾¢Â¡Ìï 
 ºÚâ¨Ç ºí¸¢º¢Ä¡ §À¾¡Íõ 
               §À¾É¡¨º§Å¡ ÀÄ§À¾ò ÐýÁ¢Â¡Ìõ 
           ¿üâ¨Ç ¿¡¸ò¾¢É¢ ºòÐÕ§ÅÂ¡Ìõ 
               ¿ÄÁ¡ÔôÒî ºò¨¾ ¿¡ºÁ¡ì¸¢î 
           ºÚâ¨Ç ¾¢Ã¢§¾¡„ ÔÃ¢ÔÁ¡Ìï 
               ¦ºôÀ¢Â§¾¡÷ §À¦ÃøÄ¡ï º¢Úâ¨Çì§¸.7 
       À¡.±ñ: 859 
                                         (§À¡¸÷ ¿¢¸ñÎ 1200).  
 
  À¡„¡½§À¾¢, ºí¸¢º¢Ä¡ §À¾¡Íõ, ÀÄ§À¾òÐýÁ¢, ¿¡¸ò¾¢ý 
ºòÐÕ, ¯ôÒî ºò¨¾ ¿¡ºÁ¡ì¸¢, ¾¢Ã¢§¾¡„ÔÃ¢ ±ýÀÉ º¢Ú¸ñÀ£¨ÇÂ¢ý §ÅÚ 
¦ÀÂ÷¸Ç¡õ.  
            Å¢Çí¸ì§¸û ºÖíÌ ç¨¸¦ÂýÚõ §ÀÕ 
                Å£Ã¡É ç½¢ýâ¦¼ýÚõ «¾üÌô §ÀÕ 
            ¯Çí¸ì§¸û ¯Ã¾¦ÁýÚõ «¾£¾ô §ÀÕ 
                ¯Ú¾¢¦ÀÚõ °ðÎÃ ãÄ¢¦ÂýÚõ §ÀÕ  
            ÁÇí¸ì§¸û °í¸É¢ ãÄ¢¦ÂýÚõ §ÀÕ  
                «ÕÇ¢§É¡ó àíÌ ã¾¡È ¦ÁýÚõ §ÀÕ  
            ÓÇí¸ì§¸û ã§¾Å¢ ãÄ¦ÁýÚõ §ÀÕ  
                Óì¸¢ÂÁ¡öî ¦º¡øÄ¢Å¢ð§¼¡ï º¢Úâ¨ÇÂ¢ý §À§Ã.3 
       À¡.±ñ: 78. 
   («¸ò¾¢Â÷ ²Á ¾òÐÅõ ±ýÛõ Àïº ¸¡Å¢Â ¿¢¸ñÎ).      
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ÀÂýÀÎõ ¯ÚôÒ: 
                 
            ºãÄõ.10 
 
Í¨Å: 
 
           ¨¸ôÒî º¨ÅÔ¨¼ÂÐ.  
 
¾ý¨Á: 
 
           ¦ÅôÀõ. 
 
À¢Ã¢×: 
 
 ¸¡÷ôÒ. 
 
¦ºö¨¸: 
 
 º¢Ú¿£÷¦ÀÕì¸¢ 
 ¸ü¸¨Ãîº¢.10 
 
®ÂîºòÐ ãÄ¢¨¸: 
 
         ´ñ½¡É ãÄ¢¨¸Â¢ø ®Âí §¸Ù 
             ¯ò¾ÁÁ¡õ ¦À¡ñ½í¸¡½¢ Í¨Ã§Â¡Î º£ó¾¢ø 
          ¾ñ½¡É ¦ºÕôÀ¨¼Ôï º¢Úâ¨Ç Å¢Ø¾¢ 
             ¦ºôÀÃ¢Â ãì¸Èð¨¼§Â¡Î Óò¦¾Õì¸ý ¦ºÅ¢¾¡ý 
          Å¢ñ½¡É ¦Åû¨Çî º¡Ã¨½Ô¼ý ¦ÅûÇÕÌ 
             Å¢ÇíÌ¸¢ýÈ Óò¾¡ Á½¢¾¡ ¦É¡ýÚí §¸Ù 
          ¿ñ½¡¸ Óý§À¡§Ä À¡Å¸§Á ¦ºöÐ 
             ºò¦¾ÎòÐ Ýò¾¢Ãò¾¢ø ¾¡ì¸¢¼¡§Â.7 
       À¡.±ñ: 478. 
          (§À¡¸÷ ¿¢¸ñÎ 1200).    
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¦À¡Ð Ì½õ: 
 
          À¡ñÎ¦ÀÕõ À¡Î À¸÷Óò¾¢ Ãì¸¢Ã¢îºÃõ 
          âñ¼¾¢Ã¢ §¾¡¼Á¢¨Å §À¡Ìí¸¡ñ - ¾¡ñÊô 
          ÀÈ¢Â§Å ¨ÇòÐÃòÐõ À¡÷¨ÅÂ¢ý¸ñ Á¡§¾! 
          º¢È¢ÂÀ£ ¨ÇìÌî º¢¨¾óÐ. 
 
          ¿£Ã¨¼ôÒ ¸øÄ¨¼ôÒ ¿£í¸¡ì Ì¼üÝ¨Ä 
          §À¡Ã¼Ã¢ Ãò¾¸½õ §À¡ìÌí¸¡ñ - Å¡Ã¢ÚìÌõ 
          âñÓ¨Ä§Â! §¸Ç¡ö ¦À¡ÕòÐï º¢ÚÀ£¨Ç 
          Â¡Á¢Ð¸ü §À¾¢ ÂÈ¢. 
       («¸ò¾¢Â÷ Ì½Å¡¸¼õ). 
               
¦À¡Õû 
                 
  À¡ñÎ, ¦ÀÕõÀ¡Î, ãò¾¢Ãì¸¢Ã¢îºÃõ, Óò§¾¡¼õ, ¿£Ã¨¼ôÒ, 
¸øÄ¨¼ôÒ, Ì¼üÝ¨Ä, þÃò¾¸½õ ¬¸¢Â §¿¡ö¸¨Ç º¢ÚÀ£¨Ç §À¡ìÌõ.10 
 
ÁÕòÐÅô ÀÂý¸û: 
 
 º¢ÚÀ£¨ÇÂ¢¨Äîº¡ü¨È 1/8 - 1/4 ¬Æ¡ìÌ Å£¾õ ÌÊòÐ ÅÃ 
¦ÀÕõÀ¡Î, ¸øÄ¨¼ôÒ, ¿£Ã¨¼ôÒ, ¿£÷ ±Ã¢îºø §À¡Ìõ. 
 
           ¸ïº¢ Å¨¸¸û ´ýÈ¢ø º¢ÚÀ£¨Ç§Å¨Ã §º÷òÐì ¸¡öîº¢ ÌÊòÐ 
ÅÃ Ýø ¦¸¡ñ¼ ¦Àñ¸ÙìÌ ÅÖ¨Åò ¾Õõ. 
                  
 º¢ÚÀ£¨Ç §Å÷ôÀð¨¼, À¨É¦ÅøÄõ Å¨¸ìÌ ÀÄõ ´ýÚ ±ÎòÐ ÜðÊ 
¨Á §À¡Ä¨ÃòÐ «¨Ã ¬Æ¡ìÌô ÀÍÅ¢ýÀ¡Ä¢ø ¸ÄóÐ ¸¡¨Ä, Á¡¨Ä 
¯ð¦¸¡ñÎÅÃ ¸øÄ¨¼ôÒ, ¿£Ã¨¼ôÒ, ¦ÀÕõÀ¡Î Ó¾Ä¢ÂÉ ¾£Õõ. 
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º¢ÚÀ£¨ÇºãÄì ÌÊ¿£÷: 
                     
 º¢ÚÀ£¨ÇºÓÄõ, º¢Ú¦¿Õïº¢ø, Á¡Å¢Ä¢í¸§Å÷, §ÀÃ¡ÓðÊ§Å÷ 
þ¨Å¸¨Ç µ¦Ã¨¼ ±ÎòÐ §À¡¾¢Â ¿£÷ Å¢ðÎ ±ðÊø ´ýÈ¡¸ ÌÚì¸¢ô ÀÕ¸ 
¸øÄ¨¼ôÒ ¿£íÌõ. ¿£Ã¢Æ¢Ôõ. 
 
 ¦Åí¸¡Ãõ, ¦ÅÊÔôÒ, º¢Ä¡òÐ, º£É¡ì¸¡Ãõ, ¸ø¿¡÷, ¿ñÎì¸ø, 
Å¢Ã¡øÁ£ý ¾¨Äì¸ø þ¨Å¸Ç¢ý ÀüÀò¨¾ ¸øÄ¨¼ôÒìÌ ÅÆíÌõ §À¡Ð 
º¢ÚÀ£¨Ç ÌÊ¿£¨Ã Ð¨½ÁÕó¾¡¸ ¦¸¡ñ¼¡ø ¿øÄ ÀÄý ¸¢¨¼ìÌõ. 
 
           º¢ÚÀ£¨ÇºãÄõ ¿£Ã¨¼ôÒ, ¿£÷ì¸ÎôÒ, ¿£÷±Ã¢îºø, ¸øÄ¨¼ôÒ, 
Å£ì¸õ Ó¾Ä¢Â ÀÄ §¿¡ö¸Ùì¸¡É ÁÕóÐ¸Ç¢ø Óì¸¢Â ãÄô 
¦À¡ÕÇ¡¸§Å¡ «øÄÐ Ð¨½ÁÕó¾¡¸§Å¡ §º÷ì¸ôÀÎ¸¢ÈÐ. þ¾¨É 
¸£úÅÕõ §Áü§¸¡û¸Ç¢É¡ø ¦¾Ã¢óÐ ¦¸¡ûÇÄ¡õ.10 
 
º¢ÚÀ£¨Ç §ºÕõ ÁÕóÐ¸û 
 
 ¾¢Ã¡ðº¡¾¢ ÝÃ½õ: 
 «Ç×: 1 - 2 ¸¢Ã¡õ, 10 Ó¾ø 20 ¿¡ð¸û. 
 «ÛÀ¡Éõ: «Ã¢º¢ ¸ØÅ¢Â ¿£÷. 
 ¾£Õõ §¿¡ö¸û: ¿£÷ì¸ðÎ, ¿£÷ ±Ã¢îºø, ¿£÷ì¸ÎôÒ.26 
 
ãò¾¢Ãì ¸¢Ã¢îºÃì ¸¢Â¡Æõ: 
 ¦¸¡ý¨È ¿Úí¸É¢Ôõ ÌÄ×¸Î ¦¿¡îº¢§Å÷ 
          ÐýÚº¢Ú â¨Ç§Å÷ §¾¡¨¼Â¢¨ÄÔ - ÁýÚ§¾ý 
          Å¢ð¼ÌÊ ¿£÷ÌÊì¸ ¦Áöãò¾¢ Ãì¸¢Ã¢îºÃõ 
          ¾ðÊÅ¢Îõ ¿£÷ì¸ÎôÒõ ¾¡ý.5  
     À¡.±ñ: 342. 
 
¸üÝÃ¡¾¢ ÝÃ½õ:            
 «ÛÀ¡Éõ: ¦¿Õïº¢ø ÌÊ¿£÷, ¾¡¨ÆÅ¢ØÐ ¿£÷. 
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 ¾£Õõ §¿¡ö¸û: ¿£÷ì¸ðÎ, ãò¾¢Ãì¸¢Ã¢îºÃõ, ¨¸ ¸¡ø ±Ã¢îºø, 20 
Å¨¸  §Á¸õ, §Â¡É¢îÝ¨Ä.5 
 
þÃò¾À¢ò¾ò¾¢üÌî ºó¾É¡¾¢î ÝÃ½õ: 
  «Ç×: ãÅ¢ÃÄÇ×. 
 «ÛÀ¡Éõ: º÷ì¸¨Ã.28 
 
þÃò¾À¢ò¾õ, ±ÖõÒÕì¸¢ìÌ ¦¿ö: 
  «Ç×: 1 ÅÃ¡¸¦É¨¼. 
 «ÛÀ¡Éõ: À¡ø, ¦¿ö. 
  ¾£Õõ §¿¡ö¸û: ¦ÀÕõÀ¡Î, ±æõÒÕì¸¢, þÃò¾À¢ò¾õ.28 
 
ãò¾¢Ã ¸¢Ã¢îºÉò¾¢üÌ ¦¸¡ý¨È§ÅÃ¡¾¢ì ¸„¡Âõ: 
 Ð¨½ÁÕóÐ:  ¦Åí¸¡Ãõ 1 ÅÃ¡¸¦É¨¼ + º÷ì¸¨Ã.28 
 
º¾¡ÅÃ¢ ¸¢Õ¾õ: 
 «Ç×: 3 ¸ÆïÍ, ¸¡¨Ä ÁðÎõ. 
 ¾£Õõ §¿¡ö¸û: ãò¾¢Ãì¸¢Ã¢îºÃõ, ¨¸¸¡¦ÄÃ¢îºø, §Á¸§¿¡ö, Íì¸¢Ä 
 À¢ÃÁ¢Âí¸û.28 
 
¸øÄ¨¼ôÒìÌ ¦ÅûÇÃ¢îº¡Ú ÁÕóÐ: 
 ¦ÅûÇÃ¢ì¸¡ö º¡Ú - 1 ¿¡Æ¢, 
 º¢Úâ¨Ç§Å÷ «¨Ãò¾ Å¢ØÐ - ±ÖÁ¢îºí¸¡ÂÇ×. 
  þÅü¨È ¸¨ÃòÐ 3 ¿¡ð¸û ¯ð¦¸¡ûÇ ¸øÄ¨¼ôÒ, ¿£Ã¨¼ôÒ 
¾£Õõ.28 
 
ãò¾¢Ã ¸¢Ã¢îºÃò¾¢üÌ ÁÕóÐ: 
          1. º¢Úâ¨ÇÂ¢¨Ä 
          2. ±ûÙôÒñ½¡ìÌ 
                     þÅü¨È ¿Íì¸¢ ´ÕÀ¡¨ÉÂ¢ø ¾ñ½£÷Å¢ðÎ §ÅÎ¸ðÊ 
«¾¢Ä¢ðÎ §Å§È¡Î À¡¨ÉÂ¡ø ãÊ «ÎôÀ¢ý §Á§ÄüÈ¢ ±Ã¢ì¸×õ. þ¾¨É 
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¿ø¦Äñ¦½Ô¼ý ¸ÄóÐ ¸¡¨Ä §¿Ãí¸Ç¢ø ¯ð¦¸¡ûÇ ãò¾¢Ãì¸¢Ã¢îºÃõ 
§À¡õ.28 
 
¿£Ã¨¼ôÀ¢üÌ ÁÕóÐ ÐÅ¡¨ÄÂ¢¼:  
 ¾¡úÅ¢ø¨Ä ¿£Ã¨¼ò¾¡ø ÁÕóÐ§¸Ù 
            ¾Ã½¢ÔûÇ §Å¡Ã¢¾ú§Å¡÷ ¸¡Êò¾ñ½£÷ 
          ÜÆ¡¸ò ¾¡É¨ÃòÐî ºÃ£Ã¦ÁøÄ¡í 
                    ÌÓÈ§Å ¾¡ýÈ¼ÀÅ ¿£÷ ¦¾Ã¢ìÌõ 
 â¨Çº¢Ú â¿£÷§Å÷ ¦À¡ýÉ¡í¸¡½¢ 
  Ò¸Æ¡Äó ÐÇ¢÷À¡Ä¢ü ¦À¡º¢ì¸ò ¾£Õõ 
 ¿¡Ç¡É ÀÄ¸¨Ã¨Âî Íð¼º¡õÀø 
            ¿øÄ§¾¡÷ À¡ñ¼ò¾¢ü Èñ½£÷ ¨Å§Â.21  
       À¡.±ñ: 160. 
 
ãò¾¢Ãì ¸¢Ã¢îºÉò¾¢üÌ: 
         §¸ðÀ¾üÌ ãò¾¢Ãì ¸¢Ã¢îº¢ §À¡¸ì 
              ¦¸ÊÂ¡É º¢Úâ¨Ç ¦¿Õïº¢§ÅÕõ 
         ................................................................. 
              .................................................................... 
         ¾£÷ôÀÐ¾¡ý ãò¾¢ ¸¢Ã¢îº¢ §À¡Ìó 
              §¾¸ò¾¢ÖûÇ ¸¡ó¾ø ¦¾Ç¢Å¾¡§Á.21 
      À¡.±ñ: 197. 
¸øÄ¨¼ôÒìÌ ¸¢Â¡Æõ: 
 Á¡Å¢Ä¢í¸¢ý§Å÷, º¢Ú¦¿Õïº¢ø§Å÷, ¦ÀÕõÀ£¨Ç, º¢ÚÀ£¨Ç, À¢Ã¡ö 
ÁÃò¾¢ý§Å÷ ºÁ±¨¼ ±ÎòÐ ÌÊ¿£Ã¢ðÎ ¦¸¡Îì¸ ¸ü¸û ¸¨ÃÔõ, ¿£Ã¨¼ôÒ 
§À¡õ.23 
 
¿£÷ì¸ÎôÒìÌ ÌÊ¿£÷ 
          ¦ºôÒ ¦¿Õïº¢ º¢Úâ¨Ç............................ 
              ............................................................±ý¦À¡ ÌÕì¸¢Ôõ 
          ¿£÷ì ¸ÎôÒ Á¢ÃñÎõ Å¢ÉÅ¢ §Â¸¢Î§Á.23  
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º¢Ú¿£÷î º¢ì¸ÖìÌ: 
          º¢ÚÀ£¨Ç§Å÷, ¦¿øÄ¢ÓûÇ¢, ¾¢ôÀ¢Ä¢, ¸üâÃº¢Ä¡ºòÐ, ²Äõ, ÁÐÃõ, 
¦¿Õïº¢ø§Å÷, ºó¾Éõ, ¦ÅûÇÃ¢Å¢¨¾ þ¨Å¸¨Ç Å¨¸ìÌ 1 ÀÄõ 
±ÎòÐì¦¸¡ñÎ ¦¸¡òÐÁøÄ¢Å¢¨¾ 1 ÀÄõ, ºí¸ý§Å÷ 1 ÅÃ¡¸¦É¨¼, 
º£É¢º÷ì¸¨Ã ºÁý ¸ÄóÐ þÇ¿£Ã¡Ä¨ÃòÐ ¸¨ÃòÐñ½×õ. 
 
þÇ¿£÷ ¦¿ö: 
 «Ç×: 5 - 6 ÅÃ¡¸¦É¨¼. 
  ¾£Õõ §¿¡ö¸û: ¸¢Ã¢îºÃ §¿¡ö, ¿£÷ì¸ÎôÒ, ¿£÷±Ã¢îºø, Íì¸¢Ä§Á¸õ, 
 ¿£÷¦Åð¨¼, ¾¡¸õ, «Éø §¿¡ö¸û.31 
 
¿£¦ÃÃ¢× ¯º¢¾õ: 
          º¢ÚÀ£¨ÇÂ¢¨Ä¨Â 1 1/4 ÀÄõ ¦Åñ¦½ö §À¡ø «¨ÃòÐ ¿£÷ 
¸Äì¸¡¾ ±Õ¨Á §Á¡Ã¢ø ¸Äì¸¢ ÀÕ¸î ¦ºöÂ×õ. 
 ¾£Õõ §¿¡ö¸û: þÕ§Å¨Ç ¯ð¦¸¡ûÇ ¿£÷ì¸ðÎ, ¿£Ã¨¼ôÒ, 
¿£¦ÃÃ¢îºø, ¿£÷ò¾¡¨Ã, «Æ¨Ä.32 
 
Á¸¡ §Á¸ Ã¡º¡í¸õ: 
 «Ç×: ¦¸¡ð¨¼ôÀ¡ì¸Ç×, þÕ§Å¨Ç, 1 Áñ¼Äõ. 
 ¾£Õõ §¿¡ö: ¸¢Ã¢îºÃõ ¬Úõ ¾£Õõ.24 
 
¸¢Ã¢îºÉõ, ¿£÷îÍÕìÌ, ±Ã¢×, þÃò¾ ´ØìÌ Ó¾Ä¢ÂÅüÈ¢üÌ ÁÕóÐ: 
 
 º¢ÚÀ£¨Ç§Å÷ôÀð¨¼, Óó¾¢Ã¢¨¸, §ÀÃ£îÍ, ¦¿øÄ¢, «¾¢ÁÐÃõ, ¬Äõ, 
¸ø¿¡÷, ¾¢ôÀ¢Ä¢, ºó¾Éõ, ÁøÄ¢, ¦ÅûÇÃ¢Å¢òÐ þÅü¨È µ÷ «ÇÅ¡öò àû 
¦ºöÐ      ¾¢Ã¢¸Ê «Ç× ÀîºÃ¢º¢ì ¸Ø¿£Ã¢ø ¯ð¦¸¡ûÇ×õ.29 
 
¸øÄ¨¼ôÒìÌ ÁÕóÐ: 
           ¦¿Õïº¢ø§Å÷, º¢ÚÀ£¨Ç§Å÷, º¢Ú¸£¨Ã§Å÷, º£Ã¸õ Å¨¸ìÌ 1 
ÀÄõ º¢¨¾òÐ §À¡ðÎ ÌÊ¿£Ã¢ðÎ ¯ð¦¸¡ûÇ×õ.29 
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¿£Ã¨¼ôÒ, º¨¾Â¨¼ôÒìÌ ÁÕóÐ: 
           ¿¡ÔÕÅ¢, º¢Ú¦¿Õïº¢ø, Å¡¨ÆîºÕÌ, ®ÕûÇ¢, º¢ÚÀ£¨Ç 
þ¨Å¸Ç¢ý º¡Ú 1/8 ÀÊ ¾ñ½£Ã¢ø ¸Äì¸¢ ¦¾Ç¢Â ¨ÅòÐ þÚòÐ «¾¢ø 
¦À¡Ã¢¸¡Ãõ, «¾¢ÁÐÃõ     1/2 ÅÃ¡¸ý ¦À¡ÊòÐô §À¡ðÎ 1 ¿¡¨ÇìÌ ¸¡ø 
ÀÊ Å£¾õ 3 §Å¨Ç ¦¸¡Îì¸×õ.29 
 
º¢Ú¿£÷, ¸øÄ¨¼ôÒìÌ ÁÕóÐ: 
           À£¨Ç§Å÷, Á¡Å¢Ä¢í¸ §Å÷, º¢Úâ¨Ç§Å÷, À¢Ã¡ÓðÊ§Å÷, 
¦¿Õïº¢ø§Å÷ ºÁ±¨¼ ±ÎòÐ þÊòÐ ´Õ À¡ò¾¢Ãò¾¢Ä¢ðÎ «ÎôÀ¢ý 
§Á§ÄüÈ¢ ±Ã¢òÐ ±ðÊ¦Ä¡ýÈ¡ì¸¢ ¦¸¡Îì¸×õ.20 
 
þÃºì¸÷ôâÃ ÁÕóÐ: 
 «Ç×: 3 ÌýÈ¢ÂÇ× º¢ÚÀ£¨Ç ¸„¡Âò¾¢ø ¦¸¡Îì¸×õ. 
 ¾£Õõ §¿¡ö¸û: ¿£÷ì¸ðÎ, ¸øÄ¨¼ôÒ, ÅÂ¢üÚÅÄ¢, þÃò¾ôÀ¢Ã§Á¸õ.30 
 
¿£Ã¨¼ôÒìÌ ¸¢Â¡Æõ: 
 º¢ÚÀ£¨Ç, Å¡øÁ¢ÇÌ, Å¡¨ÆîºÕÌ º¡õÀø, §º¡õÒ, ¦ÅûÇÃ¢Å¢¨¾ 
þÅü¨È Å¨¸ìÌ 1 §¾¡Ä¡ Å£¾õ «¨Ã ÀÊ ºÄò¾¢ø §À¡ðÎ 1/8 ÀÊÂ¡¸ì 
¸¡öîº¢ ¾¢Éõ þÕ§Å¨Ç 3 ¿¡û º¡ôÀ¢¼ ¿£Ã¨¼ôÒò ¾£Õõ.27 
 
º¢ÚÀ£¨Ç §ºÕõ À¢È ÁÕóÐ¸û : 
    
 ÓìÜðÎò ¨¾Äõ25 
 À¢ò¾ §º¡¨¸ì¸¢Â¡Æõ16 
 ¿£Ã¨¼ ôÀ¢üÌî º¡Ã¨½Â¡¾¢ì ¸„¡Âõ28 
 §º¡¨¸, ¸¡Á¡¨Ä, Å£ì¸òÐìÌ ¸¢Â¡Æõ22 
 ¸¢Ã¢îºÉõ ¬ÚìÌõ þÇ¿£÷ ÁÕóÐ30 
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BOTANICAL ASPECTS 
 
Aerva lanata (L) Juss-ex.schult 
 
 
 
CLASSIFICATION: 
 
Kingdom - Plantae 
Subkingdom - Tracheobionta 
Superdivision - Spermatophyta 
Division - Magnoliophyta 
Class  - Magnoliopsida 
Subclass - Caryophyllidae 
Order  - Caryophyllales 
Family  - Amaranthaceae 
Genus  - Aerva 
Species  - lanata (L.) A. L. Juss. ex Schultes 
 
VERNACULAR NAMES: 37 
 
Tamil   -  Sirupulai 
 
English  -  Common Wayside Weed 
 
Hindi   -  Chaya 
 
Malayalam  -  Cerupula 
 
Sanskrit  -  Bhadra , Asmabheda 
 
Telugu              -  Pindi – Kumda 
 
Kannada  -  Bili Hindi Soppu 
 
Marathi  -  Kapurmadhura  
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HABITAT: 38 
 
 The plant is distributed throughout the plains of India as a common weed in 
fields, wastelands and ascending upto 3000 feet in the hills. It is also found in Arabia, Sri 
lanka, Egypt, Tropical Africa, Java and Phillipines. In India especially in the states of 
Tamilnadu, Andra Pradesh and Karnataka.  
 
HABIT:38 
 
Perennial herb, erect or prostrate with many branches, 30 – 60 cms in height, 
wooly, tomentose throughout. 
The Leaves – simple, alternate, short petioled, densely tomentose, usually smaller 
in flowering branches.  
Flowers – very small, sessile, bisexual, hoary white often clustered in spikes.             
Perianth - calycine, membranous, five free filaments of the five stamens connate 
at the base with alternating linear staminode. 
Fruits – Greenish, roundish, compressed urticle. 
            Seeds – kidney shaped with shining black coriaceous testa. 
 
CHEMICAL CONSTITUENTS:35,36 
 
 The plant is reported to contain α – amyrin, campesterol, β – sitosterol, its 
palmitate chrysin, flavanoid and glucosides. (J. pharm. Sci.1997, 18,377) 
 It contains kaempferol – 3- galactoside, kaempferol – 3 – rhamnoside, betulin, 
hentri acontane and D-glucoside (Afaq et.al – Ethnobotany).  
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           A flavone glycoside isolated from roots and identified as Chrysin-7-O-β-
galactoside (Indian J. Chem.1979, 17B, 416) 
           A new flavanone - Aervanone isolated and its structure elucidated as 8C- β-D 
galactosyl 7, 4-dihydroxy flavone (phytochemistry 1980, 19, 1265) 
 
Aerial Parts contain 6 alkaloids namely 
Aervine (10-hydroxycanthin-6-one),  
Aervoside (10- β-D-glucopyranosyloxycanthin-6-one), 
Methylaervine (10-methoxycanthin-6-one), 
Aervolanine (3-(6-methyoxy-β-carbolin-1-yl)propionic acid, 
β – Carboline – 1- Propionic acid, 
Four β – Coumaroyl glycosides. 
 The roots also contain methyl aervin, aervin and aervoside. Two feruloylamides 
and other phenolic compounds have been reported from the herb. 
Ethno botany: 38 
Plant is widely used in south India for bladder and vesicular calculi. It is also used 
as a remedy for Oliguria, burning micturition, anasarca, and retention of urine. 
  It is used in Malabar Coast for its demulcent action, In Ceylon this plant is used as 
a remedy for cough. It is also used for its vermifuge action. 
 The plant is also useful in the treatment of boils, cephalalgia and strangury. 
Folkloric medicine of Rayalaseema region, Andhra Pradesh reports the use of 
Aerva lanata as a nephroprotector in the treatment of various kidney ailments (Vedavathy 
and Rao, 1990). The plant is also used by the Yanadi tribals of the Chittoor district as a 
diuretic and for the treatment of nephrocalcinosis and urethral stones (Vedavathy et al., 
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1997). The plant has been documented earlier for its therapeutic effects in renal diseases 
by some Unani physicians (Amin et al., 1994). In the dry zones of Sri Lanka, Aerva 
lanata has been identified for its usefulness in controlling kidney disorders (Ulluwisheva, 
1991). The roots are diuretic and demulcent. They are credited with tonic properties and 
given to pregnant women. The roots and flowers are used to cure headaches. The flowers 
are used for the removal of kidney stones and in gonorrhea.  Roots used in headache and 
also as demulcent. Decoction of the root is given as tonic to pregnant women.  Also used 
for the treatment of gonorrhea and kidney disorders, cutaneous affections and sugar in 
urine. This herb is described as "one of the best known remedies for bladder and kidney 
stones." Ayurvedic practitioners recommend a decoction of the plant to be taken 
internally for a few days to dissolves the stone and to clear the urinary path. As a tea it is 
used as a flushing-out treatment using more than 2 liters per day, sometimes combined 
with a medication for inflammations of the genitourinary tract (cystitis, urethritis), 
urinary gravel and non-obstructive stones, to prevent relapsing urinary infections, gravel 
and stones and for inflammations of the upper respiratory tract (bronchitis, pharyngitis, 
etc; coughs due to thickened bronchial section, and gastrointestinal tract.  Externally it is 
used as a poultice for minor skin inflammations. For fever:  Crush the leaves in cold 
water and bathe.38 
 
Pharmacology: 
 
Pharmacological studies confirmed that the roots possess diuretic, anti- 
inflammatory, anthelmintic, antibacterial and mild analgesic effects.35 
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It is mentioned in literatures that it also possesses demulcent, emollient, astringent 
and lithontriptic actions.  
 
The following pharmacological studies done already on the plant Aerva lanata. 
 
Acute toxicity and behavioural pattern studies: 
 
To study any possible toxic effects and / or changes in behavioural pattern, rats 
were treated with different doses of Aqueous extract of Aerva lanata (AAL) 0.5 – 4 gms / 
kg, p.o. and kept under close observations for 12 h daily for 1 week. All symptoms 
including changes in awareness, mood, motor activity, posture, motor co-ordination, 
muscle tone and reflexes were recorded for 7 days (Laurence and Bacharach, 1964). 
Results: None of the animals treated with AAL showed any visible symptoms of 
toxicity at a dose as high as 4 g/kg. There were no signs of symptoms like restlessness, 
respiratory distress, diarrhoea, convulsions, coma, etc. 
 
 Antidiabetic activity of alcoholic extract of Aerva lanata in rats: 
 
Aerva lanata (L.) Juss. ex Schultes is widely used in Indian folk medicine for the 
treatment of Diabetes mellitus. This study was undertaken to evaluate the effect of an 
alcoholic extract of A. lanata (AAL) on blood glucose and other biochemical parameters 
in alloxan-induced diabetic rats. AAL was found to reduce the increase of blood sugar in 
alloxan-induced diabetic rats (42% at 375 mg/kg and 48% at 500 mg/kg body weight). 
Chronic administration of AAL significantly (P< 0.001) reduced the blood sugar of 
alloxan induced diabetic rats for 2 weeks. Also the extract prevented a decrease in body 
weight and reduced the increased lipid peroxides in alloxan induced diabetic rats. These 
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results suggest that the AAL possesses anti-diabetic activity and is able to ameliorate 
biochemical damages in alloxan induced diabetic rats. (T. Vetrichelvan, M. 
Jegadeesan). 40 
 
Effect of Aerva lanata against hepatotoxicity of carbon tetrachloride in rats: 
 
The partially purified petroleum ether extractable fraction of the whole plant 
Aerva lanata (PF) was evaluated for the protective effect against liver damage induced by 
carbon tetra chloride (CCl4) in Sprague Dawley rats. The results showed that CCl4 
administration significantly damaged the liver as evident from histopathology and very 
high activity of serum and liver marker enzymes. It also reduced the antioxidant enzyme 
status of the animals. PF administration significantly reversed the histopathological 
changes and restored the elevated activities of liver marker enzymes and also enhanced 
the antioxidant enzyme activities. The extract also reduced hepatic lipid peroxidation and 
increased the serum total protein and albumin/globulin (A/G) ratio. Preliminary 
phytochemical analysis of PF showed the presence of alkaloids. These observations 
clearly indicate that PF contains antioxidant alkaloids capable of ameliorating the CCl4-
induced hepatic injury by virtue of its antioxidant activity. (K.G. Nevin, P.L. 
Vijayammal).41 
 
 
Antimicrobial activity and cytotoxicity of Aerva lanata: 
 
Aerva lanata whole plant showed interesting antimicrobial activities (ethyl acetate 
and methanol extracts) and significant cytotoxic properties (petroleum ether, ethyl acetate 
and methanol extracts) Dulaly Chowdhury et al.42 
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Effect of Aerva lanata on solid tumor induced by DLA cells in mice: 
Aerva lanata whole plant was extracted with petroleum ether, methanol and 
acetone. The partially TLC-purified fraction (PEF) of petroleum ether extract was proved 
to be cytotoxic to Dalton's lymphoma ascites (DLA), Ehrlich ascites (EA) and B16F10 
cell lines in vitro. Since PEF was found to be more cytotoxic to DLA cell lines, it was 
used to study the pharmacological effect and it’s potential to reduce solid tumor induced 
by DLA cell lines in mice. The result indicated that PEF significantly reduced the 
development of solid tumor in mice. (K.G. Nevin, P.L. Vijayammal) 42 
Diuretic and anti inflammatory activities of Aerva lanata in rats: 
 
Alcoholic extract of Aerva lanata was tested for diuretic activity, while the effect 
of benzene and alcoholic extracts of A. lanata were investigated in the rat to evaluate the 
anti inflammatory activity. Carrageenan-induced rat hind paw edema method was 
employed to test anti inflammatory activity. Alcoholic extract (800 mg/kg) produced 
inhibition of carrageenan-induced rat paw edema (P </-0.05). The parameters measured 
for diuretic activity were total urine volume, sodium, potassium and chloride content. The 
results clearly indicate that the alcoholic extract at a dose of 800 mg/kg act as diuretic, 
with respect to control. (Jegadeesan M, Palaniappan M .S, Murali N .P, Sasikumar K) 43 
Effect of Aerva lanata on calcium oxalate urolithiasis in rats: 
 Calcium oxalate (CaOx) stone was induced in rats using 0.75% of ethylene glycol 
in drinking water for 28 days. Administration of Aerva lanata aqueous suspension (2g/kg 
body wt/dose/day for 28 days) to CaOx urolithic rats had reduced the oxalate 
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synthesizing enzymes diminished the markers of crystal deposition in the kidney. The 
results of the study confirmed that A. lanata can be used as a curative agent for 
urolithiasis. (P Soundararajan, R Mahesh, T Ramesh & V Hazeena Begum).51 
MATERIALS AND METHODS 
 
 
PREPARATION OF DRUG 
 
 
 The drug was selected according to the reference in Gunapadam 
Mooligai Vaguppu. Page 686. 
 
 
Collection of herb: 
 
Plants were collected from Tambaram in the month of September 2006. Its 
Botanical identity was authenticated by Botany professor of National Institute of Siddha. 
The whole plants were washed in pure water, cut into small pieces and dried in sun shade. 
The dried plant is powdered. 
 
 
Preparation of drug: 
                    
The powdered plant was boiled with water of four times that of drug and made 
into ¼ th of it. The decoction was made in such a way that 1 ml of decoction contains 50 
mg of drug (5% extract). The drug was daily prepared just before administration due to 
the short shelf life of the drug (3 hours). 
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BIOCHEMICAL ANALYSIS 
 
 The Biochemical analysis of the drug Sirupeelai was done in Mettex laboratories 
of India, Chennai – 32. 
 
Quantitative Analysis: 
 
Aim: 
 To determine the metals and minerals in Sirupeelai. 
  
Instrument: 
            Atomic Absorption Spectrometer (AAS) with air – acetylene. 
 
Apparatus and Equipment: 
            500 ml glass beakers, hot plate, watch glass, 100 ml standard flask. 
 
Chemicals:  
            Nitric acid, hydrochloric acid, certified reference standards. 
 
Sample preparation: 
             Transfer a weighed Sirupeelai in to a 500 ml beaker. Add 10 ml of 1 + 1 HNO3 
and 10 ml of 1+1 HCl and heat on a hot plate until the sample gets dissolved. Cool and 
filter to remove insoluble material. Transfer sample to 100 ml volumetric flask, adjust 
volume to 100 ml and mix. Take all precautions to avoid contamination at all stages. 
Prepare a reagent blank containing same amounts of acids used in the preparation of 
sample. Aspirate the standards and sample in to AAS instrument as per instrument 
procedure. 
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Calculation: 
                                                
 Percentage of the element = A / B x 100 
                       A: Concentration of sample in ppm. 
                       B: Dilution factor.34 
                                              
Physical Properties: 
 
 
Loss on drying: 
 
 Five grams of Sirupeelai is heated in a hot oven at 40°C to constant weight. The 
percentage of loss of weight was calculated.33 
 
Determination of ash value: 
 
 Weigh accurately 2-3 grams of Sirupeelai in tarred platinum or silica dish and 
incinerate at a temperature not exceeding 450°C until free from carbon, cool and weigh. 
Calculate the percentage of ash with reference to the air dried drug. 
 
 
Acid insoluble ash: 
 
  Boil the ash for 5 minutes with 25 ml of 1: 1 dilute HCl. Collected the insoluble 
matter in Gooch – crucible on an ash less filter paper, wash with hot water and ignite, 
cool in a dessicator and weigh. Calculate the percentage of acid insoluble ash with 
reference to the air dried drug. 
 
Water soluble ash: 
 
 To the Gooch crucible containing the total ash, add 25 ml of water and boil for 5 
minutes. Collect the insoluble matter in a sintered glass crucible or on ash less filter 
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paper. Wash with hot water and ignite in a crucible for 15 minutes at a temperature not 
exceeding 450°C. Subtract the weight of the insoluble matter from the weight of the ash; 
the difference of weight represents the water soluble ash. Calculate the percentage of    
water soluble ash with reference to the air dried drug.33 
   
 
Alkalinity of water soluble ash: 
            
 Five grams of Sirupeelai converted to ash, boiled with water, filtered. Filtrate was 
titrated against 0.1N of HCl using phenolphthalein as an indicator.   
 
 Alkalinity of water soluble ash = X x  N   of acid / 0.1 x W 
            X = Titre value. 
            W = Weight of the material taken.  
 Alkalinity is given as ml of 0.1N of HCl equated to 1 gm. 
 
PH: 
           Five grams of Sirupeelai is weighed accurately and placed in clear 100 ml beaker. 
Then 50 ml of distilled water is added to it and dissolved well. Wait for 30 minutes and 
then apply in to PH meter at standard buffer solution of 4.0, 7.0, and 9.2. 
       
Qualitative Analysis: 
 
Preparation of the extract: 
 
 Five grams of Sirupeelai powder is weighed accurately and placed in clear 250 ml 
beaker. Then 50 ml of distilled water is added to it and dissolved well. Then it is boiled 
well for 10 minutes. Then cooled, filtered in a volumetric flask and then it was made up 
to 100 ml with distilled water. This fluid was taken for analysis.  
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Table 1 
 
 
S.NO 
  
                  TEST 
 
  
 OBSERVATION 
   
   INFERENCE 
   
  1. 
 
Test for calcium: 
  
     2 ml of the above prepared 
extract is taken in a clean test tube. 
To this 2 ml of 4% ammonium 
oxalate solution is added. 
 
 
 
White precipitation 
is formed. 
 
 
Presence of 
calcium. 
  
  2. 
 
Test for phosphate: 
 
       The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
 
 
 
Yellow precipitation 
is not formed. 
 
 
Absence of 
phosphate. 
 
  3. 
 
Test for flavanoids: 
Shimada test: 
      
     A few mg of the substance in 
alcohol is treated with magnesium 
and a few drops of concentrated 
HCl. 
  
 
 
 
 
Red or pink colour 
is not formed. 
 
 
 
 
Absence of 
flavanoids. 
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X RAY FLUORESCENCE STUDY 
  
 The XRF analysis of the drug Sirupeelai was done in Central Electro Chemical 
Research Institute, Karaikudi. 
 
Procedure: 
 
 The specimen in the sample holder (often rotated to improve uniformity of 
exposure) is irradiated with an unfiltered beam of primary X rays which cause the 
element present to emit their characteristic fluorescence lines. The emitted fluorescence 
lines were detected by spectrometer. 
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            PHARMACOLOGICAL STUDY 
 
 
Animals: 
                  
Healthy adult male albino rats (200 – 250gms) of Wistar strain were used for the 
study. The rats were housed in polypropylene cages and maintained under standard 
conditions (Temperature range: 65-75oF and Humidity range: 40-70%). The animals had 
free access to standard pellet diet (Amrut Laboratory Animal Feed, Nav Maharashtra 
House, Pune & Maharashtra) and water utilizing aquaguard. Study was conducted after 
obtaining Institutional Animal Ethical Committee clearance (Proposal No. 18 / 
PHARMA/CRIS, 2007). 
 
Drugs and chemicals: 
 
The following chemicals were used for the study. Gentamicin injection (Merlin 
pharma (P) Ltd Mumbai.), Estimation kit for Blood urea, Serum creatinine, Serum total 
protein, albumin and globulin (Bayer Diagnostics Ltd. Mumbai). 
 
Induction of nephrotoxicity and drug feeding schedule: 
 
Gentamicin induced renal damage: 
 
All the animals (24 Males) were weighed and randomly divided into four groups 
comprising of six rats in each. The experimental protocol for Gentamicin induced 
nephrotoxicity is cited in Table 2. The kidney damage was induced by subcutaneous 
injection of Gentamicin @ 80 mg/kg on 6th day onwards in Groups II, III and IV. Group I 
and IV were kept as normal (Saline) and toxic control group, respectively. On the other 
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hand, Group II and III were treated with Sirupeelai kudineer @ 270.0 mg/kg and 
Sirupeelai kudineer @ 500 mg/kg orally, respectively. The dose of the drug was 
calculated on the basis of results from acute toxicity studies40 (1/10th of the maximum 
tolerated dose). Blood samples were collected through retro orbital sinus of all the 
animals on 11th day of experiment. The blood samples were estimated for biochemical 
parameters such as Blood urea nitrogen, Serum creatinine, Total protein, Albumin and 
Globulin. After blood collection all the animals were weighed and euthanized under ether 
anaesthesia and the kidneys were collected, weighed and preserved in neutral buffered 
10% (V/V) formalin for histopathology. These were processed for paraffin embedding 
using ethyl alcohol as dehydrant and xylene as clearing agent. Paraffin sections of 
kidney, about 4-5 µm thickness, were stained with haematoxylin and eosin. These 
sections were examined for histopathological chenges and the cellular alterations were 
scored as Nil, +, ++ and +++ for No, Mild, Moderate and Severe damage, respectively.   
Statistical Analysis: 
The data collected were subjected statistical analysis using unpaired t-test 
(P.S.S.Sundar rao, J.Richard). The statistical significance of difference was taken as P < 
0.05. 
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Table 2 
 
 
Experimental protocol for Gentamicin model of Nephrotoxicity 
 
 
 
Group 
Number 
N = 4 
Drug 
Treatment 
Route and 
Dose 
( in mg / 
kg bw ) 
Duration 
( in days ) 
Days of 
withdrawal 
of Blood and 
Kidney 
 
Purpose 
1. 
 Saline p.o 1
st – 10th 11th Control 
2. 
Gentamicin + 
Sirupeelai 
kudineer 
80 mg / 
kg. s.c 
270 mg / 
kg. p.o 
5th – 10th 
1st – 10th 
 
11th 
 
Protective 
effect 
3. 
Gentamicin  + 
Sirupeelai 
kudineer 
80 mg / 
kg. s.c 500 
mg / kg. 
p.o 
5th – 10th 
1st – 10th 
 
11th 
 
Protective 
effect 
4. Gentamicin 
80 mg / 
kg. s.c 
 
1st – 6th 7th 
Induce 
kidney 
damage 
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RESULTS AND OBSERVATIONS 
 
 
 
Results of biochemical analysis of Sirupeelai 
 
 
Table 3 
 
 
 
      Physical properties: 
 
 
 
S.NO 
 
                        Parameters 
 
     
   Results (%) 
    
   1. 
 
   2. 
 
   3. 
 
   4. 
 
   5. 
    
   6.  
 
Loss of drying at 1050C   
         
       Ash value 
 
       Water soluble 
 
       Alkalinity as CaCo3 in water soluble ash 
 
       Acid insoluble ash  
 
       PH at 10% aqueous solution   
 
 
       7.13       
 
       7.18 
 
       10.43 
 
       0.10 
 
       1.04 
 
       5.88 
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Table 4 
 
 
    Qualitative analysis: 
 
 
 
 
 
 
 
 
 
 
Table 5 
 
 
 
Quantitative analysis: 
 
 
 
S.NO 
         
           Parameters 
 
          
         Results  
 
   1.  
 
   2. 
 
   3.  
 
   4. 
 
   5. 
  
          Potassium  
 
          Manganese 
         
          Selenium 
         
          Copper 
 
          Lead 
 
 
         2.075% 
 
         0.053% 
 
         0.043% 
 
         0.002% 
 
         0.003% 
 
 
 
 
 
 
 
 
 
S.NO            Parameters          Results 
 
   1. 
 
Calcium 
 
         Present 
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RESULTS OF PHARMACOLOGICAL STUDY 
 
BIOCHEMICAL PROFILES: 
 
In the present study Blood urea, Serum creatinine, Total protein, Albumin and 
Globulin values were estimated by using a semi autoanalyser. Mean levels of Blood urea, 
Serum creatinine, Total protein, Albumin and Globulin are presented in Table 6 and 7. 
Both the parameters (Blood urea and Serum creatinine) are excellent indicators of kidney 
lesion.48 
 In the present study the mean Blood urea, Serum creatinine, Total protein, 
Albumin and Globulin value of each group of rats at the 11th day of the experiment is 
compared with the values of nephrotoxic control group. 
 In this study the rats included in Group IV (Nephrotoxic control) showed 
significant increase in Blood urea, values compared to the values of Group I (P < 0.001). 
In the group II (Sirupeelai kudineer @ 270.0 mg/kg orally for 10 days) there was 
significant reduction in Blood urea levels as compared to that of Group IV (P < 0.05). In 
the group III (Sirupeelai kudineer @ 500.0 mg/kg orally for 10 days) there was 
significant reduction in Blood urea levels as compared to that of Group IV (P < 0.02).  
 In this study the rats included in group IV (Nephrotoxic control) showed 
significant increase in Serum creatinine values compared to the values of Group I (P < 
0.001). In the group II (Sirupeelai kudineer @ 270.0 mg/kg orally for 10 days) there was 
reduction in Serum creatinine levels as compared to that of Group IV. But the values are 
statistically non significant. In the group III (Sirupeelai kudineer @ 500.0 mg/kg orally 
for 10 days) there was significant reduction in Serum creatinine levels as compared to 
that of Group IV (P < 0.05). 
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Table 6 
 
 
Effect of Sirupeelai kudineer in Gentamicin induced renal damage 
 
 
Group  Number 
Percent Change in 
Body Weight 
Blood Urea 
( mg / dl ) 
Serum Creatinine 
( mg / dl ) 
I 5 ± 2.24 26.16 ± 1.44 0.62 ± 0.03 
II - 8.33 ± 1.67 65.83 ± 5.34 a 1.25 ± 0.05 
III 4 ± 1.86 59.67 ± 5.24 b 1.08 ± 0.04 a 
IV 5.33 ± 2.67 119 ± 20.93 c 1.5 ± 0.15 c 
 
 
Values are mean ± S.E, Unpaired t – test 
 
          a P < 0.05 Vs toxic (Gr IV ). 
          b P < 0.02 Vs toxic (Gr IV ). 
          c P < 0.001 Vs control (Gr I). 
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Table 7 
 
 
 
Effect of Sirupeelai kudineer in serum protein levels 
 
 
Group  
number 
Total protein 
 Albumin Globulin A / G ratio 
I 
 
7.75 ± 0.19 
 
  
3.1 ± 0.1 
 
4.65 ± 0.22 
 
0.67 ± 0.11 
II 
 
6.73 ±  0.19 
 
 
2.98 ± 0.06 
 
3.81 ± 0.17 
 
0.79 ± 0.03 
III 
 
6.85 ± 0.16 
 
 
   3.08 ± 0.13 
 
3.76 ± 0.13 
 
0.82 ± 0.05 
IV 
 
8.06 ± 0.37 
 
 
2.95 ± 0.12 
 
5.45 ± 0.65 
 
0.55 ± 0.03 
 
 
 
Values are Mean ± SE 
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EFFECT OF SIRUPEELAI KUDINEER ON BLOOD UREA LEVEL 
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EFFECT OF SIRUPEELAI KUDINEER ON SERUM CREATININE LEVEL 
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EFFECT OF SIRUPEELAI KUDINEER ON SERUM PROTEIN LEVELS 
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HISTOPATHOLOGICAL STUDY OF KIDNEY SECTIONS 
  
 The present study was primarily aimed at inducing nephrotoxicity in rats using 
Gentamicin. Focal interstitial nephritis, eosinophilic fluid in the lumen of tubules and 
tubular epithelial cell necrosis changes were observed in the kidney of rats and no 
mortality was seen in experimental animals, during the experiment. 
 In the sections of kidney obtained on 11th day of the experiment, there was mild 
degree of damage in group III (+1) followed by Group II (+2) as compared to damage in  
Group VI (+3). There were no changes in the sections obtained from Group I, which was 
normal control.    
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Figure No. 1 
Photomicrograph of rat kidney in Group I (Normal Control). 
 
 
 
(H & E 320x) 
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Figure No. 2 
Photomicrograph of rat kidney in Group II, treated with Sirupeelai kudineer @ 
270.0 mg/kg orally  
A. Section showing focal interstitial nephritis. 
 
 
B. Section showing eosinophilic fluid accumulation in the lumen of tubules. 
 
(H & E 320x) 
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Figure No. 3 
Photomicrograph of rat kidney in Group III, treated with Sirupeelai kudineer @ 500 
mg/kg orally showing eosinophilic fluid accumulation in the lumen of tubules. 
 
(H & E 320x) 
 
Figure No. 4 
Photomicrograph of rat kidney in Group IV (Nephrotoxic Control), treated with 
Gentamicin @ 80mg /kg, intramuscularly showing tubular epithelial cell necrosis.  
 
(H & E 320x) 
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DISCUSSION 
  
 The dried powdered plant of Sirupeelai was selected to find its efficacy in the 
management of Neeradaippu. 
 
 The literature review of the drug Sirupeelai strongly supports the 
Nephroprotective action. Sirupeelai is used as a single drug or in combination with other 
drugs for the treatment of Neeradaippu or moothira kiricharam - mentioned in many 
siddha literatures. Apart from these it was also indicated for sobai (anasarca) and Raktha 
pittham (hypertension) which are complications of Neeradaippu. 
  
Review of articles about the plant Aerva lanata reveals hepatoprotective, anti 
oxidant, anti diabetic, anti inflammatory, diuretic and anti microbial activities. Petroleum 
ether extract of Aerva lanata showed a significant reduction in lipid peroxidation in liver 
microsomes. Its effect on anti oxidant enzymes on liver also studied by K G Nevin, P.L 
Viyammal on 2005 (Abstract of these articles are written on page 18 – 20). 
 
The present study aims to protect the kidney damage induced by Aminoglycocide 
(AG) like Gentamicin in rat model. AG on intracellular bioactivation produces reactive 
oxygen species and lipid peroxidation in kidneys. The results of various studies suggested 
that treatment of rats with hydroxyl radical scavengers protect against Gentamicin 
induced renal damage.46 
 
 Biochemical analysis of the drug Sirupeelai reveals the presence of minerals 
namely Selenium, Manganese, Lead, Copper, Potassium and Calcium. 
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Selenium:46  
 Selenium prevents lipid peroxidation and protects the cells against the free 
radicals including super oxide. Selenium involved in the maintainence of structural 
integrity of biological membranes. Selinium as selenocysteine is an essential component 
of enzymes Glutathione peroxidase, which protects the cells against oxidative damage by 
hydro peroxidases. Thus it acts as a potent antioxidant; prevent renal damage by free 
radicals. It also facilitates digestion and absorption of lipids including vitamin E which is 
a potent antioxidant. 
Manganese: 
 Manganese is a micronutrient which is predominantly stored in the bones, liver, 
kidney, and pancreas. It has antioxidant properties and is needed to activate a number of 
enzymes, helps the body to absorb vitamin B1 (thiamine) and vitamin E. Haemoglobin 
synthesis also involves Manganese. Manganese inhibits lipid peroxidation.49 
 Manganese is a component of the antioxidant enzyme manganese superoxide 
dismutase (MnSOD). Antioxidants scavenge damaging particles in the body known as 
free radicals. These particles occur naturally in the body but can damage cell membranes, 
interact with genetic material, and possibly contribute to the aging process as well as the 
development of a number of health conditions and organ damage. Antioxidants such as 
MnSOD can neutralize free radicals and may reduce or even help to prevent some of the 
damages of organs they cause. 
Zinc: 
 The zinc content of the adult human body ranges from 1.4 to 2.5 grams, with the 
highest concentrations in the bone, liver, kidney, pancreas, pituitary, prostatic gland and 
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muscle tissue. Erythrocyte contains higher content of zinc in association with carbonic 
anhydrase enzyme. 
 Zinc also comprises the structure of copper/zinc-superoxide dismutase (Cu/Zn-
SOD). Zinc plays a structural role in Cu/Zn-SOD. Zinc may also have antioxidant 
activity via its association with the copper-binding protein metallothionein. 
 Zinc assists in maintaining the proper concentration of vitaminE  in the blood. 
Zinc is known to have antioxidant properties being a membrane stabilizer, scavenging 
reactive oxygen metabolites and regulating cytokine synthesis through the activation of 
transcription factors. Moreover, the element stimulates tissue healing and repair in 
experimental ulcers directly through promoting cell proliferation, protein synthesis and 
growth factors production and scavenging free radicals 
 A growing body of evidence suggests a role for zinc in antioxidant defence 
systems. The metal has only one stable oxidation state (divalent) and is not affected by 
free radicals or oxidative stress. It may act as a scavenger of radical products through the 
synthesis of enzymes such as superoxide dismutase (SOD) and metallothionein (MT) or it 
may affect cytokine-activated transcription factors. (J. Trace Elem. Exp. Med. 13:33-39, 
2000. © 2000 Wiley-Liss, Inc). 
Copper: 
 Copper is found throughout the musculo-skeletal system, although the largest 
amounts are found in the brain and liver.  
 Copper, through its involvement in the formation of several key enzymes is not 
only involved in the release of energy inside the cell, but also contributes to the function 
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of very many antioxidants, assisting the "mopping up" of the free radicals that cause cell 
damage. 
Copper necessary for synthesis of hemoglobin. Ceruloplasmin serves as 
ferroxidase and is involved in convertion of iron from Fe2+ to Fe3+ in which form, iron is 
transported in plasma. It is an important component of cytochrome oxidase - controls 
intracellular energy production. It protects against free radical damage as a component of 
superoxide dismutase and is needed for Vitamin C to be effective. 
Calcium: 
 Calcium plays a vital role in capillary permeability and muscle contractility. The 
function of the nephron depends on capillary permeability and blood circulation to the 
glomeruli.49 A diet rich in calcium reduces Amino Glycoside (AG) nephrotoxicity.45 
 Calcium and Magnesium ions exert antagonistic effects on cell permeability. In 
case of renal function impairment there is a raise in serum magnesium levels. This can be 
reversed by corresponding amounts of calcium administration. Hence calcium 
administration during renal function impairment may be ideal. 
Potassium: 
 Potassium also plays a vital role in the preservation of the permeability of cells. 
Long standing potassium deficiency may cause injury to myocardium and severe renal 
damage leading to chronic renal diseases. Hence potassium supplements in patients with 
renal damage may be helpful. 
Lead: 
Plumbum metallicum (Lead) is used in the treatment of Diabetes mellitus with 
constipation, and protein overflowing into the urine (which is determined by urinalysis). 
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X-Ray fluorescence studies on the drug Sirupeelai reveals the presence of 
minerals namely Zinc, Iron, Calcium and Potassium.  
Iron: 
Iron plays a vital role in the transport of Oxygen to tissues and participation in 
cellular oxidation mechanism. Anaemia is one of the complications of chronic renal 
damage.47 Iron supplements may support the patients with chronic renal damage. 
 
Pharmacological Studies: 
 
 The pharmacological action of the drug Sirupeelai was carried out in Central 
Research Institute for Siddha, Arumbakkam,Chennai. 
 
 Nephroprotective activity in rat models using Wistar albino rats, carried out in 
Gentamicin induced renal damage. The rat is a suitable animal model for studies of AG 
nephrotoxicity in humans since pharmacokinetics and toxicology of AG are remarkably 
similar in rats and human.45 The study demonstrates renal damage in toxic groups, 
evidenced by elevated blood urea, serum creatinine levels and histopathological features 
of acute tubular necrosis, the protective groups administered with the decoction of 
Sirupeelai at the dose of 5.4 ml and 10 ml / kg bw along with Gentamicin showed 
protective effects on renal damage evidenced by reduction in blood urea and serum 
creatinine levels and histopathological studies.  
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Recent concept about antioxidants: 
 Many of the synthetic antioxidants like flavanoids, synthetic vitamins and 
minerals are not working as antioxidants while the natural products containing crude 
drugs with fibrous products act as anti oxidant and free radical scavengers.50 
 “Whatever is behind the health benefits of a diet rich is fruits and vegetables, we 
cannot reproduce it by taking purified extracts and vitamin supplements”. The vitamins, 
carotenoids and poly phenols in fruits and vegetables are bound into tough fibrous 
material, they hang around the stomach and colon, where they can neutralize free radicals 
in the gastro intestinal tract. 50  
 
In siddha system of medicine many of the drugs are used in crude forms as natural 
products, they may act better than synthetic drugs. What the siddhars are doing since 
years may give proper solution for many chronic ailments. Hence the westernization of 
siddha medicine should be prohibited but its potential to prove its worth through 
scientific tests of verifiability and reproducibility should be encouraged. 
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Siddha aspect:  
 
 According to siddha concept Neeradaippu is a condition due to vitiated Azhal 
humor. Azhal humour can be normalized by the tastes namely kaippu, inippu and 
thuvarppu. This is mentioned in siddha literature as the verse  
 
                     À¢ò¾ Á¾¢¸Ã¢ôÀ¢ý §ÀÍõ ÀÃ¢¸¡Ãõ 
                     Íò¾ò ÐÅ§Ã¡Î ¦º¡øÄ¢É¢ôÒî ºò¾¡Ìõ 
                     ¨¸ôÒî Í¨Å§Â ¸Õ¾Å¾ý Å£Ú 
                     ±öôÀ¨¼Ô ¦ÁýÚ¨Ãò¾¡ Ã¢íÌ 
 
                       (¸ñÏº¡Á¢Âõ) 
 
 The drug Sirupeelai has kaippu suvai which normalizes Azhal humour. One of the 
basic principles of siddha called Ethirurai (normalization with drugs having opposite 
potential) works in this case. 
 
 Along with vitiated Azhal humour Vazhi and Iyyam also combines and produce 
edematous condition of the body, periorbital oedema and abdominal distension. In siddha 
literature it was mentioned that the drug Sirupeelai has diuretic action. This action 
enables the symptomatic relief of oedema. Other associated symptoms like dyspnoea, 
giddiness are also subside when oedema gets releived.  
 
In siddha literatures it was mentioned that the herb Sirupeelai has Vanga chatthu 
i.e Lead (Pb) content. 
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 º£¨¾Óò¾¢ Õì¸ï ¦ºÅ¢¦Åû¨Çî º¡÷§Å¨Ç 
 À¡Ð¨¸§Å Ä¢ôÀÕò¾¢ ÓŠ¨¾Ôõ - §¸¡¾¢øÍ¨Ã 
 º£ó¾¢ø Å¢Ø¾¢ º¢ÚÀ£¨Ç ¦ÅûÇÚÌõ 
 ²ó¾¢¨ÆÂ£ Ã£Âã Ä¢.11 
 
 This verse indicates that Sirupeelai is one of the plants containing Lead content. 
Karuvangam (Lead) has diuretic, antimicrobial actions and it was used by Siddhars for 
many chronic disorders like Pervaiyaru. Calcinated product of Karuvangam was 
indicated for Mahotharam, Neer arugal etc. 
 The condition Neeradaippu characterised by oliguria and retention of metabolic 
waste products in body. The other names of the drug Sirupeelai mentioned as. 
 
 º¢Úâ¨Çô §À÷¾¨É§Â ¦ºôÀì§¸Ù 
               .................................................... 
               ¿ÄÁ¡ÔôÒî ºò¨¾ ¿¡ºÁ¡ì¸¢î 
 ................................................................... 
               ¦ºôÀ¢Â§¾¡÷ §À¦ÃøÄ¡ï º¢Úâ¨Çì§¸7.........859 
  
                                                       (§À¡¸÷ ¿¢¸ñÎ 1200) 
 
 The name Uppu chatthai nasamakki may be given by Siddhars for its action to 
reduce the salt content (blood urea) of the blood. 
 
All the above aspects of Sirupeelai give a clear picture of its efficacy in the 
management of Neeradaippu. 
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SUMMARY AND CONCLUSION 
 
 
 The drug of Sirupeelai has selected for the study to evaluate its efficacy in the 
management of Neeradaippu. 
 
 The literature collection describes the Nephroprotective activity of Sirupeelai. 
Review of Journals describes the antioxidant activity of the herb Sirupeelai 
. 
 The chemical analysis of the drug Sirupeelai reveals the presence of minerals 
namely Selenium, Manganese, Lead, Copper, Zinc, Iron, Calcium and Potassium. 
 
 Pharmacological studies showed that the drug has significant nephroprotective 
activity at the dose of 5.4 ml and 10 ml / kg bw and no significant adverse effects. 
  
 Sirupeelai is an easily available drug. 
 
 Preparation of the drug SirupeelaiKudineer is also very simple and economical. 
 
 Each and every study of the drug Sirupeelai gives a new hope in the management 
of Neeradaippu. 
 
 It can be concluded that the Nephroprotective activity of the herb Aerva lanata 
may be due to the presence of antioxidants. Further, the nephroprotective and curative 
effect of the drug on chronic renal damage had to be studied. Its effect on lipid 
peroxidation in kidneys and antioxidant enzyme status in kidneys during treatment with 
Sirupeelai have to be evaluated. 
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ABSTRACT 
 
 
 The drug VediAnnabedhi Chendhooram (VABC) was selected to study its efficacy 
in the management of Kaamalai. The biochemical analysis, XRD and XRF studies of the 
drug were done to found out the chemical nature of the drug. In pharmacological aspect 
the Hepatoprotective activity of the drug was studied in CCl4 induced hepatic damage in 
wistar albino rats of either sex. The rats in prophylactic group were treated with 
VediAnnabedhi Chendhooram with honey at the dose of 23.4 mg and 50 mg / kg for 14 
days and standard drug Silymarin at the dose of 100 mg / kg. The results showed that 
CCl4 administration significantly damaged the liver and the drug administration 
significantly reduced the level of liver marker enzymes, increase the total protein content 
and minimize the Histopathological changes. The observations clearly indicate that the 
drug VediAnnabedhi Chendhooram with honey possess Hepatoprotective activity with 
minimal toxicity and could offer promising role in the management of liver damage 
caused by CCl4. 
 
 
 
 
 
 
 51
INTRODUCTION 
 
Siddha system has its own well developed chemistry and Siddhars tireless striving 
in the direction of development has resulted in genesis of thousands of mineral and 
metallic preparations. There is no doubt that Siddha medicine is derived from alchemy. 
Siddhars are the pioneers in the use of metals and minerals in treatment of diseases. 
 
Siddhars had classified the chemicals into metals of 11 varieties, salts of 25 
varieties, 64 toxic substances (pashanam) and 120 uparasas (auxiliary substances). This 
was given in Bhogar Karasara Thurai as, 
 
 §¸ÇôÀ¡ ¸¡Ã¦Á¡Î º¡Ãó ¾¡Ûõ 
  ¦¸ðÊÂ¡ Â¢ÕÀÐ¼ ÉïÍ Á¡îÍ 
 ¾¡ÇôÀ¡ ×ÀÃºáü È¢ÕÀ ¾¡Ìõ 
  ¾¡Â¡É ¿Å§Ä¡¸õ À¾¢¦É¡ý È¡îÍ  
 ¿¡ÇôÀ¡ À¡¼¡½ Å¨¸§Â ¦¾ýÈ¡ø 
  ¿ÄÁ¡É ÅÚÀòÐ ¿¡Ä ¾¡îÍ 
 ÝÇôÀ¡ Å¢¨Å¦ÂøÄ¡ ¦Á¡ýÈ¡öî §º÷ì¸ò 
  ¦¾¡¨¸Ô¦Á¡Õ Å¢Õá§È¡ ÊÕÀ ¾¡î§º.11 
 
According to Bhogar even a single drug with dietary regimen, can cure several 
diseases by varying its anupaanam (adjuvant) such as honey, water, butter etc. It is 
postulated that the success of Siddha medicine depends upon its carrier, which also varies 
according to seasons and body conditions of the patient. One of the texts by Theran – 
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Theraiyar Venpa declares that the drugs are potentiated by the efficacy of the adjuvant 
used. 
 
 «ÛÀ¡Éò ¾¡§Ä ÂÅú¾í¸ð ¸¡ñ¨Á 
 ¸ÉÁ¡Ì ¦Áý¨Á¦ÂøÄ¡í ¸¡ðÎõ- þÉÁ¡É 
 §À¾¡§À ¾í¸¦ÇøÄ¡õ §À¾¢ò ¾È¢ó¾Å§Ã 
 ¿¡¾¡ì¸ ¦ÇýÛÁ¨È ¿¡ø. 
                                                   (§¾Ãý ¦ÅñÀ¡) 
 
There is a tacit belief that the adjuvant used for a drug would also modify the 
potency of drug and curative capability synergistically for better therapeutic results.  
 
The drug Vediannabedhi Chendhooram with honey is indicated for Kaamalai 
(Jaundice) which is a condition characterized by yellowish discoloration of sclera skin 
and mucosa. According to Yugi Vaidhiya Chindhamani, Kaamalai is a condition due to 
vitiated Azhal humour and it has 13 subdivisions. But in the indication of drug 
Vediannabedhi Chendhooram it was mentioned generally for Kaamalai and not for any 
particular type of Kaamalai. 
 
According to modern science the aetiological classification of Jaundice reveals 3 
main types viz hepatocellular, obstructive and haemolytic. Among these, Jaundice due to 
hepatocellular damage is more common and there is a continuous search for agents which 
provide protection and cure for liver cell damage. In this dissertation Hepatoprotective 
action of drug Vediannabedhi Chendhooram have been evaluated. 
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AIM AND OBJECTIVES 
 
Aim: 
 
 The aim of the dissertation is to evaluate the efficacy of Vediannabedhi 
Chendhooram in the management of Kaamalai.  
 
Objectives: 
 
 Hepatocellular damage is one of the major causes of Kaamalai (Jaundice). There 
are several causes for hepatocellular damage like drugs, chemicals, food poisoning by 
aflatoxins, alcohol and infections like viral hepatitis and some other protozoal infections. 
Most of the causes of liver damages are unpreventable. There are plenty of herbal 
medicines which are proved to have protective and curative effect on hepatocellular 
damage, irrespective of the cause of damage.  
 
 In siddha literature some of the salts and minerals are indicated for Kaamalai. In 
that way Annabedhi and Vediuppu are used as one of the ingredients in many siddha 
preparations indicated for Kaamalai. Lemon juice which was used in the preparation of 
drug contains many citroflavanoids which act as potent antioxidant and free radical 
scavengers. Lemon is one of the rejuvenating medicines according to siddha aspect. All 
these aspects drove the author to evaluate hepatoprotective action of Vediannabedhi 
Chendhooram. 
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The efficacy of Vediannabedhi Chendhooram has to be discussed in the following 
aspects: 
 
 Collection of literature evidences in 
 Gunapadam aspect 
 Chemical aspects 
 Botanical aspect 
 Biochemical analysis  
 X Ray fluorescence spectrometric studies 
 X Ray diffraction studies 
 Pharmacological studies 
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 GUNAPADAM ASPECT 
 
 
«ýÉ§À¾¢ 
 
 
§ÅÚ ¦ÀÂ÷¸û: 
 
             «ýÉ §À¾¢¨Â «¨ÈÂì §¸Ù 
                 ¬¾¢ì¸ø ¿¡¾Á¡õ «ýÉì¸¡Äý 
             ¸ýÉÁ¡õ §À¾¢Â¡í¸ø ºÅÎ¿¡¾í 
                 ¸ÉÁ¡É ¸Ç¢õÒ¾¡ý ¸øÖ §Å¸ï 
             º¢ýÉÁ¡õ §À¾¢Â¡õÅ¨Ä Å£Ã¢ÂÁ¡Ìõ 
                 ¾¢Ã¡Å¸òÐì ¸Îí¸¡Ã¢ §À¾¢Â¡Ìõ 
             ÁùÅÉÁ¡õ §À¾¢Â¡ Á¨ÄÕÐ×Á¡Ì 
                 Á¡ºüÈ ÅýÉ¦ÁýÈ §À¾¢¾¡§É.7      
       À¡.±ñ: 114.    
                                         (§À¡¸÷ ¿¢¸ñÎ 1200).     
 
À¢ÈôÒ: 
 «ýÉ§À¾¢ ±ýÈ "¸¡º£ºõ" Á¨ÄÂ¢ø ¯üÀò¾¢Â¡¸¢ýÈÐ. ¨ÅôÒ 
Ó¨ÈÂ¢ø þÕõÒ ¸õÀ¢Ô¼ý ¸ó¾¸ò¾¢Ã¡Å¸õ §º÷òÐ ¸¡öîº¢ 
¦ºöÂôÀÎ¸¢ÈÐ.11 
¾ý¨Á¸û: 
 þÐ ¸ðÊ¸Ç¡Ôõ, Àî¨º¿¢ÈÁ¡Ôõ ÀÇ¢íÌì¸ø §À¡ýÚÁ¢ÕìÌõ. þÐ 
¿£Ã¢ø ¸¨ÃÔõ, º¡Ã¡Âò¾¢ø ¸¨ÃÂ¡Ð. þ¾ý§Áø ¸¡üÚÀð¼¡ø ¦Åñ¨ÁÂ¡É 
àÇ¡öÅ¢Îõ. 
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Í¨Å: 
 ÐÅ÷ôÒ. 
 
Å£Ã¢Âõ: 
 ¦ÅôÀõ. 
 
¦ºö¨¸:  
 ¯¼ø ¯ÃÓñ¼¡ì¸¢, ÐÅ÷ôÀ¢, ÕÐ ¯ñ¼¡ì¸¢, ¿¡üÈÁ¸üÈ¢, 
ÒØì¦¸¡øÄ¢, Ó¨È ¦ÅôÀ¸üÈ¢. 
 
«Ç×:  
 ´ýÚ Ó¾ø ãýÚ «Ã¢º¢¦Â¨¼.(65 - 195mg) 
 
Íò¾¢ Ó¨È¸û: 
 
 «ýÉ§À¾¢¨Â ÒÐµðÊÄ¢ðÎ º¢Åì¸ ÅÚòÐ ±ÎòÐì¦¸¡ûÇ 
Íò¾¢Â¡Ìõ.12 
 §¾¨ÅÂ¡É «ýÉ§À¾¢¨Â ¿£Ã¢ø ¸¨ÃòÐî º¢È¢¾Ç× ¸ó¾¸ò ¾¢Ã¡Å¸õ 
Å¢ðÎ ÅÊ¸ðÊ, ¯ôÒ ¯¨ÈÔõ ÀìÌÅò¾¢ø ¸¡öîº¢ì ¦¸¡ûÅ§¾ Íò¾¢Â¡õ. 
 
¦À¡Ð Ì½õ: 
 
          Ó¨ÇÅ¢Ã½ï Ý¨ÇÁó¾ Óð¼¡¨Áì ¸ðÊ 
          Å¢¨ÇÂÈýÁ §¸¡¾Ã§¿¡ö Å£ðÎõ - Å¨ÇÁ¨Ä§À¡ü 
          ¸¡ðÎÁýÉó ¾ý¨Éì ¸½ò¾¢ü ºÄÁ¡ì¸¢ì  
          ¸¡ðÎÁýÉ §À¾¢ÂÐ ¸¡ñ. 
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 «ýÉò¨¾ ¿£Ã¡ö¸¨Ãì¸¢ýÈ «ýÉ§À¾¢ Ó¨Äì¸ðÊ, Ý¨Ä, 
«ƒ£Ã½õ, À¡ö¸¢ýÈ ¬¨Áì¸ðÊ, Å£È¢Âº§Ä¡¾Ãõ þ¨Å¸¨Ç ¿£ìÌõ. 
  
 þ¾¨Éô À¡ñÎ, Ý¾¸ôÀ¡ñÎ, º£¾ì¸ðÎ, ¸ÕôÀôÀ¢Ã§Á¸õ, ¸¡öîºø 
¸ðÊ, Ó¨ÈîÍÃõ, ±Ø»¡Â¢Ú, ¿¡ðÀð¼ ¸ì¸¢ÕÁø, ¾ð¨¼ì¸¢ÕÁ¢ §Ã¡¸õ 
Ó¾Ä¢Â À¢½¢¸ÙìÌ ¯ûÙìÌõ, «ì¸¢, §Á¸ Å¢Ã½õ, º£úãÄõ, ¬ºÉÅ¡ö 
¦ÅÇ¢ôÀ¼ø, ¸ÕôÀÅ¢Ã½õ Ó¾Ä¢Â À¢½¢¸ÙìÌ §ÁÖìÌõ ¯À§Â¡¸¢ì¸Ä¡õ. 
  þ¾¢ø «Âõ þÕôÀ¾É¡ø þÕõÀ¢É¡ø ¾£Õõ À¢½¢¸û ¿£íÌõ.11 
 
 
«ýÉ§À¾¢ §ºÕõ ÁÕóÐ¸û 
 
«ýÉ§À¾¢ ¦ºóàÃõ: 
 
            «ýÉ§À¾¢ - 2 Àäõ(70mg) º¢Ú¿£Ã¡ÅÐ ÀÆîº¡È¡ÅÐ Å¢ðÎ À¢ðÎ 
§À¡ø ¸¢ÇÈ¢ ¨ÅòÐ §Á§Ä¡Î ãÊ º£¨ÄÁñ ¦ºöÐ 10 ±ÕÅ¢ø Ò¼õ§À¡¼ 
¦ºóàÃÁ¡Ìõ. 
  «Ç×: À½¦Å¨¼, þÕ§Å¨Ç. 
 «ÛÀ¡Éõ: §¾ý, ¦¿ö. 
  ¾£Õõ §¿¡ö¸û: À¡ñÎ, ¸¡Á¡¨Ä, Á§¸¡¾Ãõ, ¦ÀÕÅÂ¢Ú, Å£ì¸õ.14 
 
§º¡¨¸ìÌ «ýÉ§À¾¢ì ÌÆõÒ: 
 
 «Ç×: ¦¿øÄ¢ì¸¡ÂÇ×, þÕ§Å¨Ç, 1 Áñ¼Äõ. 
 ¾£Õõ §¿¡ö¸û: À¡ñÎ, §º¡¨¸, ¸¡Á¡¨Ä, Á§¸¡¾Ãõ, ¸×¨º, 
¿£Ã¡õÀø,  À¢ò¾ò¾¡ø ÅÕõ §¿¡ö¸û.17 
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«‰¼ ÌýÁ þ§Ä¸¢Âõ: 
 
  «Ç×: 5 Àäõ (175mg), À¨É¦ÅøÄòÐ¼ý ´Õ §Å¨Ç. 
  ¾£Õõ §¿¡ö¸û: «ñ¼ Å¡¾ ÌýÁõ, ¦ÀÕÅÂ¢Ú, Å¡ö× ¾¢Ãðº¢, 
¯ôÀ¢ºõ,  ¦¸ñ¨¼.2 
 
«ýÉ§À¾¢ ÀüÀõ: 
  ¾£Õõ §¿¡ö¸û: §Á¸õ 20, ¯‰½ §¿¡ö¸û «¨ÉòÐõ ¾£Õõ.8 
 
Á¸¡ §¸¡¼¡ ÝÃ¢ Á¡ò¾¢¨Ã: 
 
   «Ç×: ÀÂÈÇ× Á¡ò¾¢¨Ã. 
   Ð¨½ ÁÕóÐõ ¾£Õõ §¿¡ö¸Ùõ:   
  §º¡¨¸, ¸¡Á¡¨ÄìÌ ¾¡ýÈ¢ì¸¡ö ¦À¡ÊÂ¢Öõ      
  À¢ò¾ò¾¢üÌ ÍìÌ, Á¢ÇÌô ¦À¡ÊÂ¢Öõ 
  À£Ä¢¨¸, ¿£Ã¡õÀø þÅüÈ¢üÌ ÐõÁðÊì¸¡ö Ãºò¾¢Öõ 
¦¸¡Îì¸×õ.14 
º÷Å §¸¡¼¡ ÌÇ¢¨¸: 
  «Ç×: ÀÂÈÇ× Á¡ò¾¢¨Ã. 
  «ÛÀ¡Éõ: ¦ÅüÈ¢¨Äî º¡Ú. 
  ¾£Õõ §¿¡ö: ¸¡Á¡¨Ä.9 
 
«ýÉ§À¾¢ §ºÕõ À¢È ÁÕóÐ¸û 
 Å£Ã ¦ºóàÃõ16    
 «ýÉ§À¾¢ ¾¢Ã¡Å¸õ18 
      º¡Ãô À¾í¸õ18  
 ¦Åû¨Çô ÀÊ¸¡Ã ¨ÅôÒ18 
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                                     ¦ÅÊÔôÒ 
 
§ÅÚ ¦ÀÂ÷¸û: 
 
             ¯ôÀ¡É ÒÃ¾õ «ÀÃ¾¡ ¦ÉýÚõ 
                 ´ÕÁ¡¾ì ¸Õô¦ÀýÚ Á¾üÌô §ÀÕ 
             «ôÀ¡É Õò¾¢Ã ¯ô¦ÀýÚõ §ÀÕ 
                 «ó¿¾¦ÉýÈ ¯ôÀ¾üÌ Å¾£¾ô ¦ÀÂ÷¸û  
             ¦ºôÀ¡É ¦ºÂÄ¸ ×ÁÔô ¦ÀýÚõ §ÀÕ 
                 ¦ºí¸ÊÅ¡Ôô ¦ÀýÚÁÐìÌô §ÀÕ 
             ¾ôÀ¡Áü ¦º¡øÖ¸¢§È¡õ ¿ÅüÌô ¦ÀýÚõ  
                 ¾¡À¢ò§¾¡õ ¾Á¢ú ¦ºö§¾¡÷ ¦ÅÊÔôÀ¢ý§À§Ã.3  
       À¡.±ñ: 95 
                        («¸ò¾¢Â÷ ²Á ¾òÐÅõ ±ýÛõ Àïº ¸¡Å¢Â ¿¢¸ñÎ),       
         
               
   ¦Å¡ð¼¨ÇÁ¢ý §À÷¾¨É§Â ¦À¡Õó¾ì §¸Ù 
                 §ÀÃ¡É À¨¼ÂÃºý þ½í ¸É¡Ìí 
             ¸ð¼¨ÇÂ¢ý âÉ¡¾õ âÁ¢ì Ü÷¨Á 
                 ¸Õ¾¢Â§¾¡÷ À¼ÄÅ½í ¸ÕÅ¡ÓôÒ 
             «ð¼¨Ç Â¢ë„Ãò¾¢ ÄÅ½¦ÁýÚ 
                 «ì¸¢É¢ìÌ ¯Â÷¸¢§È¡ý ¬ñ ¨ÁÔû§Ç¡ý  
             «ð¼¨ÇÂ¢ý ºí¸ò¾¢ý ºòÐÕÅ¡Ì  
                 ¿Åîº¡Ã Á¢òÐÕ ¦ÅýÈÈ¢ó¾¢Ë§Ã¡.7 
       À¡.±ñ: 28.   
                                        (§À¡¸÷ ¿¢¸ñÎ 1200).     
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         ¦À¡ðÊÖôÒ, þ½í¸ý, À¨¼Ã¡ºý, âÁ¢ Ü÷¨Á, ¿Åîº¡Ã Á¢òÕ, 
Å¡¾ò¾¢üÌ §Å÷. 
 
¦À¡Ð Ì½õ: 
 
          ÁøÄ¡Õ Áð¼ÌýÁ Á¡Õ¾ Ãì¸ðÊ 
          ¸øÄ¡ Á¨¾ôÒ¿£÷ì ¸ð¼Õ¸ - ¦ÄøÄ¡§Á 
          ¸õÀ¢¸õÀ¢ ¦ÂýÚí ¸Õ×ñ¼¡ Áí¸¢¿¢ýÈ 
          ¸õÀ¢¸õÀ¢ ¦ÂýÚ¨ÃìÌí ¸¡ø. 
 
          Ý¾¸ Å¡Ô¦Å¡Î §º¡½¢ò¾¢ý Å¡¾Óõ§À¡õ 
          Å¡¾ÅÄ¢ ÌýÁÁ¢¨Å Á¡Úí¸¡ñ - Á£¾¡í 
          ¦¸¡ÊÂ ÅÂ¢È¢Æ¢Ôí §¸¡¨Æ¸À §ÁÌõ 
          ¦ÅÊÔôÒò ¾ý¨É Å¢ÇõÒ. 
 
              ¦ÅÊÔôÀ¢É¡ø ±ñÅ¢¾ ÌýÁõ, ¸ÕôÀ¡ºÂì ¸ðÊ, §º¡¨À, 
ãò¾¢Ãì¸¢Ã¢îºÃõ, ¿£÷îÍÕìÌ, Ý¾¢¸¡Å¡¾õ, Å¡¾§º¡½¢¾õ, º¡Á¡É¢Â Å¡¾ 
À¢ò¾ ¸À ÌýÁí¸û, ¦ÀÕÅÂ¢Ú, ®¨Ç, ¸À§¾¡¼õ, ÍÃõ, Å£ì¸õ, ¸£øÅ¡¾õ 
þ¨Å ´Æ¢Ôõ. §ÀÃ¢Çõ ¦Àñ ÀÕÅí ¸¼ó¾ Á¡¾÷¸ðÌõ ¸ÕôÀõ ¯ñ¼¡Ìõ. 
þ¾É¡ø ÍÃõ, Å£ì¸õ, ¸£øÅ¡¾õ, þÃò¾ À¢ò¾õ, À¢Ã§Á¸õ, ¸ñ§½¡ö, 
¦¾¡ñ¨¼ Å¢Ã½õ, ÍÅ¡º¸¡ºõ Ó¾Ä¢ÂÉ×õ ¿£íÌõ.11 
 «Ç×: 5 - 10 ÌýÈ¢¦Â¨¼ (650 Á¢.¸¢ 1.3 ¸¢Ã¡õ). 
 
¦ºö¨¸: 
 ÌÇ¢÷îº¢ ¯ñ¼¡ì¸¢, Å¢Â÷¨Åô ¦ÀÕì¸¢, º¢Ú¿£÷ô¦ÀÕì¸¢. 
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Àïºâ¾ìÜÚ:   
 §¾Ô.11 
¿ðÒîºÃìÌ¸û: 7 
          ÀÊ¸¢, þóÐôÒ, ¸øÖôÒ, ¦Åí¸¡Ãõ, Ä¢í¸õ, Å£Ãõ, Ðò¾õ, ¾¡Ç¸õ, 
¿¡¸õ, ¸¼øÑ¨Ã, ¿¢Á¢¨Ç. 
 
À¨¸îºÃìÌ¸û: 7 
 ¸¡Ã£Âõ, ¦ÅûÇ£Âõ, ÐÕÍ, ¦ÅûÇ¢, ¦ºõÒ, Ý¼ý, þÕõÒ, ¸¡ó¾õ, 
º¢¨Ä, ¦¸ó¾¢, º¢í¸¢, ¾£ÓÚ¸ø, «ñ¼§Å¡Î.             
Íò¾¢ Ó¨È¸û:     
    
 ¦ÅÊÔôÒ ´Õ Àí¸¢üÌ, ¿¡ýÌ ÀíÌ ¾ñ½£÷Å¢ðÎ «Îô§ÀüÈ¢î 
º¢Ú¾£Â¡ø ±Ã¢òÐì ¦¸¡¾¢¸¢ÇõÒõ§À¡Ð, 1 Å£¨º ¯ôÒìÌ ¿¡ýÌ §¸¡Æ¢ 
Óð¨¼ ¦Åñ¸Õ¨Åî §º÷ì¸ §ÅñÎõ. §Á§Ä «ØìÌò ¾¢ÃÙõ. «¾¨É 
«¸ô¨ÀÂ¡ø ÅÆ¢òÐ ¿£ì¸¢, ¯¨ÈÔõ À¾ò¾¢ø ÁÚºðÊÂ¢ø º£¨Ä¸ðÊ «¾¢ø 
ÅÊòÐì ¸¡üÈ¢øÄ¡Â¢¼ò¾¢ø ¨ÅòÐ, ÁÚ¿¡û ¿£¨Ã ÅÊòÐ Å¢ðÎ, 
ÝÃ¢Â¦Å¡Ç¢Â¢ø ¯ô¨À ¯Ä÷ò¾×õ. þùÅ¡Ú ²Ø Ó¨È ¦ºöÂ Íò¾¢Â¡õ. 
 
          ¦ÅÊÔôÒ 1 ÀíÌ, ¸¼ø ¿£÷ «øÄÐ ¿£÷ 2 ÀíÌ ±ÎòÐ ¯ô¨À 
Ññ¨ÁÂ¡öô ¦À¡Ê¦ºöÐ ¿£Ã¢ø ¸ÄóÐ ¨Åì¸ ¿£Ã¢ø ¸ÄóÐ§À¡õ. 
¦¾Ç¢¦ÅÎòÐ ¦Åñ¨ÁÂ¡É þÕôÒô À¡ñ¼ò¾¢ø Å¢ðÎì ¸¡öîº¢, ¯¨ÈÔõ 
À¾ò¾¢ø §ÅÚ ´Õ ¦ºôÒô À¡ñ¼ò¾¢ø ¦¸¡ðÊ ÌÇ¢÷ó¾ þ¼ò¾¢ø ¬È¨Åì¸ 
¯ôÀ¡Ìõ. «¨¾ ±ÎòÐ, «¾üÌ 2 ÀíÌ ¿£÷Å¢ðÎ §ÁüÀÊÂ¡¸§Å ¸¡öîº¢ 
¯ôÀ¡ì¸×õ. þôÀÊ ¦Á¡ò¾ò¾¢ø 5 Ó¾ø 7 Ó¨È ¦ºöÂ Íò¾¢Â¡õ. 
  
      ÍÃò¾¢ø ¸¡Ïõ ¿¡ÅÈðº¢, ¾¡¸õ, ¿£÷ì¸ÎôÒ, §¾¡ø ÅÈðº¢ 
þ¨Å¸ÙìÌ ¦À¡ðÊÖôÒ 2 ÅÃ¡¸¦É¨¼¨Â 1 §º÷ ¸ïº¢Â¢ø ¸ÄóÐ 
Í¨Åì¸¡¸ò §¾ý «øÄÐ ¸ü¸ñÎ ÜðÊ «Õó¾Ä¡õ. 
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¦À¡ðÊÖôÒò ¾¢Ã¡Å¸õ: 
 
            ¦À¡ðÊÖôÒ 20 ÀÄõ, ÀÊ¸¡Ãõ 16 ÀÄõ, ¸¼¨Äô ÒÇ¢ôÒ ¿£÷ 18 
ÀÄõ þ¨Å¸¨Ç ´ýÚÀ¼ì ¸ÄóÐ, ¾¢Ã¡Å¸õ þÈìÌõ Å¡¨ÄÂ¢Ä¢ðÎ 
Ó¨ÈôÀÊ ±Ã¢òÐò ¾¢Ã¡Å¸ò¨¾ì ÌôÀ¢Â¢ø Å¡í¸¢ì ¦¸¡ûÇ×õ. 
 ¾£Õõ §¿¡ö:  ¾ì¸ «Ç× ¿£Ã¢ø ¸ÄóÐ ¦¸¡Îì¸ º¢Ú¿£¨Ã 
«¾¢¸ôÀÎòÐõ. 
 
§ÅÚ Ó¨È: 
 
          ¦À¡ðÊÖôÒ 8 ÀÄõ, þóÐôÒ 8 ÀÄõ, Å¨ÇÂÖôÒ 8 ÀÄõ, ÀÊ¸¡Ãõ 8 
ÀÄõ, §º¡üÚôÒ 8 ÀÄõ, ±ñ¦½ö ¦Åí¸¡Ãõ 8 ÀÄõ, ÐÕÍ 1 ÀÄõ, 
¿Åîº¡Ãõ 1 ÀÄõ þ¨Å¸¨Çô ¦À¡ÊòÐò ¾¢Ã¡Å¸õ þÈìÌõ ¸ÕÅ¢Â¢Ä¢ðÎ, 
Ó¨ÈôÀÊ ±Ã¢òÐò ¾¢Ã¡Å¸ò¨¾ì ÌôÀ¢Â¢ø Å¡í¸¢ì ¦¸¡ûÇ×õ. 
      ¾£Õõ §¿¡ö¸û:  þ¾¨Éò ÐÇ¢ì¸½ì¸¢ø ¿£Ã¢ø ¸ÄóÐ 
ÌÆó¨¾¸ÙìÌì ¦¸¡ÎòÐÅÃì ¸øÄ£Ãø, Áñ½£Ãø Å£ì¸õ Ì½Á¡Ìõ.11 
 
¦ÅÊÔôÒ §ºÕõ ÁÕóÐ¸û 
 
Áïºð¸¡Á¡¨Ä ¯º¢¾õ:    
               ¦ÅÊÔôÒî Íñ½õ - 4 ÌýÈ¢¦Â¨¼. 
               §¸¡Ð ¦¸¡ð¨¼ ¿£ì¸¢É ÒÇ¢ - 1 ÅÃ¡¸ý «Ç× ¾ñ½£Ã¢ø 
¸¨ÃòÐ ¾¢ôÀ¢¨Â ¿£ì¸¢Å¢ðÎ «¾¢ø ¦ÅÊÔôÒî Íñ½ò¨¾ ¸ÄóÐ ¦¸¡ûÇ 
§ÅñÎõ. 
 
  ¾£Õõ §¿¡ö:  þÕ§Å¨Ç, 3 ¿¡û ¦¸¡ûÇ Áïºð¸¡Á¡¨Ä.13 
 
À¡ñÎ ¦ºÂ¿£÷:   
  «Ç×: 1- 2 ÅÃ¡¸ý(4.2 - 8.4gm), þÕ§Å¨Ç. 
  «ÛÀ¡Éõ: ÓûÇí¸¢î ¦ºÂ¿£÷. 
  ¾£Õõ §¿¡ö¸û:  À¡ñÎ, ¿£÷ì¸ðÎ, Á§¸¡¾Ãõ, ÅÂ¢üÚÅÄ¢.13 
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À¡ñÎ §Ä¡¸ ¦ºóàÃõ:   
  «Ç×: 1/2 - 1 ÅÃ¡¸ý.(2.1 -4.2gm) 
  «ÛÀ¡Éõ: §¾ý, ¦¿ö, ¦Åñ¦½ö. 
  ¾£Õõ §¿¡ö¸û: ¸¡Á¡¨Ä, ÌÕ¾¢ìÌ¨È× §¿¡ö.13 
 
Ã¡ƒ ÄÅ½î ÝÃ½õ:  
 «Ç×: ¾¢Ã¢¸Ê, ¦Åó¿£Ã¢ø. 
  ¾£Õõ §¿¡ö¸û:  ÌýÁõ 8, Å¡Ô, «ƒ£Ã½õ, ÅÂ¢üÚÅÄ¢, 
ÀÄÁ¡É§Ã¡¸í¸û.14 
 
ÄÅ½î ÝÃ½õ: 
  «Ç×: 1 ÅÃ¡¸¦É¨¼, ¸¡¨ÄÂ¢ø ¿£Ã¡¸¡Ãò¾¢ø. 
  ¾£Õõ §¿¡ö¸û: ÌýÁõ, ÅÂ¢üÚô¦À¡ÕÁø, ¯¾Ã§Ã¡¸õ.14 
 
¸Å¢¨º ¦ºÂ¿£÷:   
  «Ç×: 1 - 2 ÅÃ¡¸¦É¨¼. 
  Ð¨½ ÁÕóÐ: þÇ¿£÷, ÓûÇí¸¢îº¡Ú, ¦¿Õïº¢ø ÌÊ¿£÷. 
  ¾£Õõ §¿¡ö¸û: ¸Å¢¨º, À¡ñÎ, ¸¡Á¡¨Ä.4 
 
Ý¨Äô À¢¼¡Ãõ: 
  ¾£Õõ §¿¡ö¸û: À£Ä¢¨¸, ¿£Ã¡¨Á ÅÄ¢, ÅÂ¢üÈ¢ø ²üÀÎõ À¢½¢¸û.5 
 
Á¸¡ º¡÷òàÄ¡¾¢ì ÌÇ¢¨¸: 
  «Ç×: Íñ¨¼ì¸¡ÂÇ×, Å¢ÊÂü¸¡¨ÄÂ¢ø ÁðÎõ. 
  ¾£Õõ §¿¡ö¸û: À£Ä¢¨¸, Á§¸¡¾Ãõ, ¿£Ã¡õÀø, «Ì¨Å, ¦ÅôÒôÀ¡¨Å,        
 Ì¨Ä ¸×º¢ Ó¾Ä¢ÂÉ.6 
 
²Ãñ¼ò ¨¾Äõ: 
  «Ç×: 1/4 §¾¡Ä¡(3gm). 
  Ð¨½ ÁÕóÐ: Á¢ÇÌì ÌÊ¿£÷, ¦¸¡ûÙì ÌÊ¿£÷. 
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  ¾£Õõ §¿¡ö¸û: Á§¸¡¾Ãí¸û, ¸Å¢¨º, ¦ÅôÒôÀ¡¨Å, «Ì¨Å, 
¿£Ã¡õÀø,  À¡ñÎ, ¯¾¢Ãì¸ðÊÉ¡ø ÅÕõ §¿¡ö¸û.6  
 
ÌÁðÊì¸¡ö ÌÆõÒ:  
  Ð¨½ ÁÕóÐ: ¦ÅøÄò¾¢ø º¢È¢Ð ÁÕóÐ ÜðÊ ¯ñ½ §ÅñÎõ. 
  ¾£Õõ §¿¡ö¸û: ¿£Ã¡õÀø, ¸Å¢¨º, À¡ñÎ, Á§¸¡¾Ãõ, ÅÂ¢üÚ 
§¿¡ö¸û.6 
 
ÌÁðÊì¸¡öì ¸ÎÌ: 
  «Ç×: 1 ÅÃ¡¸¦É¨¼(4.2gm). 
  ¾£Õõ §¿¡ö¸û: Á§¸¡¾Ãõ, ¦ÅôÒôÀ¡¨Å, À£Ä¢¨¸, ¿£Ã¡õÀø, ¸Å¢¨º,  
 ÅÂ¢üÚ§¿¡ö.6 
 
Á§¸¡¾Ãò¾¢üÌ ¸Îì¸¡ö ¾¢Ã¡Å¸õ: 
  ¾£Õõ §¿¡ö¸û: ¦ÀÕÅÂ¢Ú, Á§¸¡¾Ãõ, Å¢„ §Ã¡¸í¸û Â¡×õ 
«¸Öõ.15 
 
¦ÅÊÔôÒ §ºÕõ À¢È ÁÕóÐ¸û 
 
 ¦ÅÊÔôÒ ¾¢Ã¡Å¸õ 8 
 ¿Å§Ä¡¸ò¾¢Ã¡Å¸õ 18 
 þÃº ¦ºóàÃ ¾¢Ã¡Å¸õ18 
 ¸¡Ç¢ºí¸ò ¾¢Ã¡Å¸õ18 
 Ðò¾Á¡Ã½ò ¾¢Ã¡Å¸õ18 
 «Âºí¸ò ¾¢Ã¡Å¸õ18 
 º¢¸ôÒ ºùÅ£Ã ¨ÅôÒ8              
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 «ýÉ§À¾¢, ¦ÅÊÔôÒ §ºÕõ ÁÕóÐ¸û 
 
Á§¸¡¾Ã ÄÅ½ þÇ¸õ:  
 
  «Ç×: 1 - 2 ÅÃ¡¸ý(4.2-8.4gm), þÕ§¨Ç, «¨Ã Áñ¼Äõ. 
  «ÛÀ¡Éõ: þÇ¿£÷, ¸£Æ¡¦¿øÄ¢ ºãÄì ÌÊ¿£÷. 
 ¾£Õõ §¿¡ö¸û: Á§¸¡¾Ãõ, ¦ÀÕÅÂ¢Ú, ¸×¨ºì ¸ðÊ, ¯¾¢Ãì¸ðÊ, 
 ÌýÁì¸ðÊ, ÍÃì¸ðÊ, ÀïºÀ¡ñÎ.13 
 
¦ÅÊÔôÒ «ýÉ§À¾¢ Á¡ò¾¢¨Ã:    
 
   «Ç×: 1 Á¡ò¾¢¨Ã, 3 §Å¨Ç. 
   «ÛÀ¡Éõ: §¾ý. 
 ¾£Õõ §¿¡ö¸û: ÍÃì¸ðÊ, Å£ì¸õ. 19 
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±ÖÁ¢î¨º 
 
§ÅÚ ¦ÀÂ÷¸û: 
 
                  ºõÀ£Ãõ, §¾º¢¿£÷, ¿¢õÀÅÇîº¡Ú, ¯¼øÀ¢ò¾ÓÈ¢Á¡¾÷, 
§ÀÍí¸É¢Á¡¾÷, º¢Ú¸¢Ç¢Â¢ý ÀÆîº¡Ú, §¿¡Å¡Ç¢ Á¡¾Ã¢, Ü¾Æîº¡Ãõ ±ýÀÉ. 
 
Í¨Å: 
 ÒÇ¢ôÒ. 
 
¾ý¨Á: 
 ¦ÅôÀõ. 
 
À¢Ã¢×: 
 ¸¡÷ôÒ. 
 
¦ºö¨¸: 
 ÌÇ¢÷îº¢Ôñ¼¡ì¸¢. 
 
¦À¡ÐÌ½õ: 
 
        ¾£¦¾Ö Á¢îºí¸¡ö §¼÷Óò§¾¡ ¼ò¨¾ÔÓû 
        Å¡¾¸À Ý¨Ä¨ÂÔõ Á¡¦¸¡ÊÂ – º¡¾¢¦ÂÛï 
        º÷ò¾¢Ìý Áò¨¾ÔÓû ¾í¸ÁÕó ¾¢ð¼ò¨¾Ôõ 
        À¢ò¾¦Åô¨À Ôó¾½¢ìÌõ §ÀÍ. 
      («¸ò¾¢Â÷ Ì½Å¡¸¼õ). 
            ±ÖÁ¢îºí¸¡ö ÓìÌüÈõ, Ý¨Ä, Å¡ó¾¢, ÌýÁõ, þÎÁÕóÐ, 
«Æø þ¨Å¸¨Çô §À¡ìÌõ. 
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 §ÁÖõ Áó¾¢Ã¢ ±ÉìÜÚõ ¾£ìÌüÈò¨¾ò ¾½¢ìÌõ, ¾ó¾¢Ã¢Â¡¸¢Â 
³Âò¾¢üÌ       «ýÀý§À¡Ä¢ÕóÐ «É¨Ä ÅÇ÷ìÌõ. þ¾¨É  
           
 Áó¾¢Ã¢ìÌ Áó¾¢Ã¢Â¡ö ÁýÉÛìÌ ÁýÉ¦ÉÉò 
          ¾ó¾¢Ã¢ìÌ Á¢ò¾¢Ãý§À¡ü º¡Õ§Á - Óó¾ÅÕ 
          ¸õÀ£Ã Á¡öî ºÃì¸¢ý ¦¸ñ½¢ÂÁ¡ö Å¡¸¼÷ìÌî 
          ºõÀ£Ã Á¡¦ÁÖÁ¢î ¨º. 
       (§¾Ãý ¸¡ôÀ¢Âõ). 
±ýÛõ ¦ºöÔÇ¡ø «È¢ÂÄ¡õ. 
 
            ÍÃò¾¢ø ¯ñ¼¡Ìõ Å¡ó¾¢¸ðÌõ, Å¡öÌÁð¼ÖìÌõ 
þôÀÆÃºò¾¡ø ¦ºöÂôÀÎõ º¡¾¢ºõÀ£ÃìÌÆõÒ ¿üÀÂý ¾Õõ. §ÁÖõ 
À¢ò¾§¿¡öÌìÌ ÀÂýÀÎõ «§É¸ ÁÕóÐ¸Ç¢ø þ¾ý º¡Ú §º÷ì¸ôÀÎ¸¢ÈÐ.10 
 
 ±ÖÁ¢îºõ ÀÆõ ¸üÀ ÁÕóÐ¸Ç¢ø ´ýÚ. þ¾¨É ÃºÓõ °Ú¸¡ÔÁ¡¸ 
¸üÀÓ¨ÈÂ¡¸ô Àò¾¢ÂòÐ¼§É 6 Á¡¾õ ¯ð¦¸¡ûÇ ¿¨Ã, ¾¢¨Ã Á¡Úõ. 
À¢ÊôÒ, ¦ÀÕÅÂ¢Ú, Àì¸ Ý¨Ä, Ó¼õ, ¦ÅÈ¢, ÁÂì¸õ, ÁÉî§º¡÷× 
±ýÀ¨Å¸Ùõ «Ê§Â¡Î ¿£íÌõ. þ¾¨É  
           
           §¸¡½ò Ð¨ÇÔí ÌÈ¢Ô¨ÇÔí ¦¸¡ì¸¡¸¢ô 
           §¸¡½ò Ð¨ÇÔí ÌÕ¨Ç§À¡ü - §¸¡½î 
           º¼Á¾¢Ôñ Á¡È¡Áü ºõÀ£Ãì ¸üÀï 
           º¼Á¾¢Ôñ Á¡È¡Áü ºñ.1 
                                                  (§¾Ãý ÂÁ¸ ¦ÅñÀ¡). 
±ýÛõ ¦ºöÔÇ¡ø «È¢ÂÄ¡õ. 
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CHEMICAL ASPECT 
 
 
Ferrous sulfate: 
 
It is a blue-green monoclinic crystalline water-soluble salt. It loses water of 
hydration to form the monohydrate, a white, monoclinic, crystalline powder that occurs 
naturally as the mineral szomolnokite 
 
Other names: 
 
Ferrous sulfate, green vitriol, copperas, melanterite, szomolnokite. 
 
Physical & Chemical Properties 
 
Colour - brown/green crystilline solid                        
Density 1.898 g/cm3 
Melting point 64°C 
Boiling point 90°C (becomes FeSO4·H2O) 
FeSO4.7H2O - 90 % 
MgSO4.7H2O - 4 % 
pH > 1 (10 % solution ) 
Other metal sulphates - 1 % 
Insolubles - 0.1 % 
Free acid - 0.3 % 
Residual moisture - 5 % 
Fe (active substance) - 18 % 
Dissolves easily in water 570 g/l (20 deg C) 
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Not to be used in 
Decreased numbers of red blood cells in the bloodstream caused by an increase in 
their breakdown (haemolytic anaemia) 
Iron storage disorder (haemosiderosis) , hemochromatosis 
 
Known sensitivity or allergy to any ingredient  
 
Use with caution in 
 Inflammatory bowel disease such as ulcerative colitis or Crohn's disease  
 Narrowing of the gut  
 
Side effects: 
Medicines and their possible side effects can affect individual people in different 
ways. The following are some of the side effects that are known to be associated with this 
medicine. Because a side effect is stated here, it does not mean that all people using this 
medicine will experience that or any side effect.  
 Abdominal pain  
 Constipation  
 Diarrhoea  
 Nausea and vomiting  
Black or darker than normal appearing stools, or temporary    staining of 
the teeth 
Uses: 
In Indian system of medicine Annabedhi is used as an alterative, diuretic, 
haematinic and for the treatment of enlarged liver. It is also used for debility following on 
Malaria, Kala-azar etc. 
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Potassium nitrate 
 
 
Other names: 
 
              Saltpetre,  Nitrate of potash 
 
Physical data: 
 
Appearance: As colorless, prismatic crystals or as a white powder 
Melting point: 334 C  
Boiling point: ca. 400 C (decomposes)   
Density (g cm-3): 2.11  
Water solubility: appreciable  
Decomposes below boiling point at 400°C 
Melting point: 333-334°C 
Density: 2.1 g/cm^3 
 
Toxicology 
Harmful if swallowed. May cause reproductive disorders.  
ORL-RBT LD50 1901 mg kg-1  
ORL-RAT LD50 3750 mg kg-1  
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Actions of Potassium nitrate: 
                       
                             Potassium nitrate in solution is a refrigerant, efficient diuretic and 
diaphoretic. It acts on vascular systems and thus reduces the frequency of pulse. 
 
Uses: 
 
      It is useful in early stages of dropsy and recovery of internal organs affected by 
fever.22 
 
Laghu sanskha dravagam: 
                    
                              It smells strongly of nitrous fumes. It is prepared by using Country 
nitre - 6 palams, Alum – 4 palams, Yavakshara, Ammonium chloride, Borax – each 2 
palams and Gandham, Vediuppu, Sodium carbonate, Annabedhi, Thurusu – each 1 palam 
powdered and distilled. 
                               The distillation product is recommended for the relief of all liver 
complaints. 
                Tested by Dr. Koman – he said cases with cirrhosis of liver with ascites doing 
some good, improved prognosis.22   
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Citrus limon (linn) Burm.F. 
 
Classification: 
 
 Class  : Dicotyledons 
 
 Subclass : Polypetalae 
 
 Series  : Disciflorae 
 
 Family  : Rutaceae 
 
 Genus  : Citrus 
 
 Species : limon 
 
 
Vernacular names:37   
 
 
 Tamil  : Elumichai 
 
 Sanskrit : Jambira, Nimbu phala 
 
 English : Lemon 
 
 Telugu  : Nimma 
 
 Unani  : Leemu, Baraa neebu 
 
 
Habitat:38 
 
 Tropical parts of India, commonly found in Kumaon, northern and central India. 
 
 
 
 
Habit:38 
  
 A lemon tree can grow up to 10 meters, but they are usually smaller. The 
branches are thorny, and form an open crown. The leaves are green, shiny and elliptical. 
Flowers are white on outside with a violet streaked interior and have a strong fragrance.    
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 The citrus fruit is special kind of berry called Hesperidium. Hesperidium is almost 
unique to the genus of citrus, oblong or globose in shape but of various sizes. The 
Hesperidium has a thick oil-gland dotted rind, green when unripe turning yellow as the 
fruit ripens; a thin, papery white albido on the inside of the rind and a many chambered 
endocarp with a few seeds in each chamber. From the inner walls of each chamber, grow 
transverse juice-called hairs, which constitute the edible part of the fruit.  
 
 
Chemical constituents:35,37 
 
  Limonene is a principal constituent of essential oil. Others are Citronellal, n – 
nonanal, n- decanal, n – dodecanol , linalyl-acetate, geranyl acetate, citronellyl acetate, 
methyl anthrailate and lipophilic flavanoids including sinensetin and furocoumarins. 
 The chief flavanoids are bitter neohesperidine naringin and neohesperidin, 
dihydro chalcones, hesperidine and rutin. 
 It also contains glycosyl apigenin, β-Caryophyllene, limocitrol, limocitrin, 
abscisic acid, gibberellic acid, abscisinП, auxin and isorhamnetin. 
 
Fresh lemon juice contains minerals such as Zinc, Selenium, Manganese, 
Magnesium, Molybdenum, Iron, Copper, Phosphorus, Sodium, Potassium, Fluoride, 
Iodine, Chromium, Chloride and Calcium. It also contains vitamin A, pantothenic acid, 
Thiamin, niacin, riboflavin, vitamin B6, vitamin B12, biotin, vitaminC, vitamin E and 
vitamin K.  
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MATERIALS AND METHODS 
 
                       PREPARATION OF DRUG 
 
 
 The drug was selected according to the reference in Gunapadam 
2&3 part. Page 529. 
 
Purification of Drug: 
 
 
Purification of Annabedhi: 
 
The raw drug Annabedhi was powdered well, kept in a mud vessel and fried well 
until it was completely oxidized. The purified Annabedhi is whitish in colour and 
powdery in nature. 
 
Purification of Vediuppu: 
 
The raw drug Vediuppu was powdered well and dissolved in water of four times 
that of drug and boiled. At the time of boiling lemon juice was added and the waste 
products floating on the surface of it was removed. Then it was filtered by using cloth 
and kept undisturbed for one day. The next day water content was filtered off and the salt 
at the bottom was dried in sunlight. The same process was repeated for 7 times. The 
purified salt was glossy white in colour. 
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Preparation of drug: 
 
 Purified Annabedhi – 35 grams and purified Vediuppu – 8.75 grams were 
powdered well and grinded in a mortar with lemon juice for 3 hours. After that it was 
subjected to 3 pudam (application of heat using cow dung cakes) until the colour of it 
turns into reddish brown. Then it was powdered well and preserved. It was mixed with 
honey and stock solution was prepared in such a way that 1 ml solution contains 10 mg of 
drug. 
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BIOCHEMICAL ANALYSIS 
 
 The Biochemical analysis of the drug Vediannabedhi Chendhooram was done in 
Mettex laboratories of India, Chennai – 32. 
 
Quantitative Analysis: 
 
Aim: 
 To determine the metals and minerals in Vediannabedhi Chendhooram. 
  
Instrument: 
 Atomic Absorption Spectrometer (AAS) with air – acetylene. 
 
Apparatus and Equipment: 
            500 ml glass beakers, hot plate, watch glass, 100 ml standard flask. 
 
Chemicals:  
            Nitric acid, hydrochloric acid, certified reference standards. 
 
Sample preparation: 
 Transfer a weighed Vediannabedhi Chendhooram in to a 500 ml beaker. Add 10 
ml of 1 + 1 HNO3 and 10 ml of 1+1 HCl and heat on a hot plate until the sample gets 
dissolved. Cool and filter to remove insoluble material. Transfer sample to 100 ml 
volumetric flask, adjust volume to 100 ml and mix. Take all precautions to avoid 
contamination at all stages. Prepare a reagent blank containing same amounts of acids 
used in the preparation of sample. Aspirate the standards and sample in to AAS 
instrument as per instrument procedure. 
 
Calculation:                                                
 Percentage of the element = A / B x 100 
                       A: Concentration of sample in ppm. 
                       B: Dilution factor.34 
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Physical Properties: 
 
Loss on drying:  
 Five grams of Vediannabedhi Chendhooram is heated in a hot oven at 40°C to 
constant weight. The percentage of loss of weight was calculated.33 
 
Determination of ash value: 
 Weigh accurately 2-3 grams of Vediannabedhi Chendhooram in tarred 
platinum or silica dish and incinerate at a temperature not exceeding 450°C until free 
from carbon, cool and weigh. Calculate the percentage of ash with reference to the air 
dried drug. 
 
Acid insoluble ash:            
 Boil the ash for 5 minutes with 25 ml of 1: 1 dilute HCl. Collected the insoluble 
matter in Gooch – crucible on an ash less filter paper, wash with hot water and ignite, 
cool in a dessicator and weigh. Calculate the percentage of acid insoluble ash with 
reference to the air dried drug. 
 
Water soluble ash:             
 To the Gooch crucible containing the total ash, add 25 ml of water and boil for      
5 minutes. Collect the insoluble matter in a sintered glass crucible or on ash less filter 
paper. Wash with hot water and ignite in a crucible for 15 minutes at a temperature not 
exceeding 450°C. Subtract the weight of the insoluble matter from the weight of the ash; 
the difference of weight represents the water soluble ash. Calculate the percentage of    
water soluble ash with reference to the air dried drug.33   
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Alkalinity of water soluble ash: 
   
 Five grams of Vediannabedhi Chendhooram converted to ash, boiled with water, 
filtered. Filtrate was titrated against 0.1N of HCl using phenolphthalein as an indicator.  
 
 Alkalinity of water soluble ash = X x  N of acid / 0.1 x W 
            X = Titre value. 
            W = Weight of the material taken. 
 Alkalinity is given as ml of 0.1N of HCl equated to 1 gram. 
PH: 
            
 Five grams of VABC is weighed accurately and placed in clear 100 ml beaker. 
Then 50 ml of distilled water is added to it and dissolved well. Wait for 30 minutes and 
then apply in to PH meter at standard buffer solution of 4.0, 7.0, and 9.2. 
 
 
Qualitative Analysis: 
 
Preparation of the extract: 
 
                       Five grams of Vediannabedhi Chendhooram is weighed accurately and 
placed in clear 250 ml beaker. Then 50 ml of distilled water is added to it and dissolved 
well. Then it is boiled well for 10 minutes. Then cooled, filtered in a volumetric flask and 
then it was made up to 100 ml with distilled water. This fluid was taken for analysis.  
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Table 8 
 
 
S.No.                    Test  Observation  Inference 
    1. Test for calcium: 
2 ml of the above prepared extract is 
taken in a clean test tube. To this 2 ml of 
4% ammonium oxalate solution is added. 
 
 
White 
precipitation is 
formed. 
 
 Presence of 
calcium. 
  2. Test for phosphate: 
The extract is treated with ammonium 
molybdate and concentrated nitric acid. 
 
 
Yellow 
precipitation is not 
formed. 
 
 Absence of 
phosphate. 
  3. Test for flavanoids: 
Shimada test: 
A few mg of the substance in alcohol is 
treated with magnesium and a few drops 
of concentrated HCl. 
  
 
 
Red or pink colour 
is not formed. 
 
 
 Absence of 
flavanoids. 
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X RAY FLUORESCENCE STUDY 
  
  
The XRF analysis of the drug Vediannabedhi Chendhooram was done in Central 
Electro Chemical Research Institute, Karaikudi. 
 
Procedure: 
 
 The specimen in the sample holder (often rotated to improve uniformity of 
exposure) is irradiated with an unfiltered beam of primary X rays which cause the 
element present to emit their characteristic fluorescence lines. The emitted fluorescence 
lines were detected by spectrometer. 
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X- RAY POWDER DIFFRACTION (XRD) 
 
 
The XRD analysis of the drug Vediannabedhi Chendhooram was done in 
Department of Nuclear physics, University of Madras. 
 
The powder method of diffraction was devised independently by Debye and 
Scherrer. Powder diffraction method involves the diffraction of monochromatic X- rays 
by a powder specimen. Monochromatic usually means a strong Kα characteristic 
component of the filtered radiation from an X- ray tube operated above the K α excitation 
potential of the target material. 
 
Selection of Kα renders the incident beam to be a highly monochromatised one. 
The focusing monochromatic geometry results in narrower diffracted peaks and low 
background at low angles. The sample is mounted vertically to the Seemann- Bohlin 
focusing circle with the scintillation counter tube moving along the circumference of it. It 
is possible to record the diffracted beam from 2 to 160 degrees. The diffractometer is 
connected to a computer for data collection and analysis. The scintillation counter tube 
can be moved in step of 0.01 degree by means of a stepper motor and any diffracted beam 
can be closely scanned to study the peak profile.    
 
 Identification of the material:  
 
The powder diffraction of a substance is characteristic of the substance and forms 
a sort of fingerprint of the substance to be identified. The peaks of the X-ray diffraction 
pattern can be compared with the standard available data for the conformation of the 
structure. For the purpose of comparison, many standards are available, some of which 
are, Willars hand book, Joint Committee on Powder Diffraction Standards (JCPDS) 
Pepdfwin and National Bureau of Standards. 
 
 
 82
PHARMACOLOGICAL STUDY 
 
Animals: 
 
Healthy adult male albino rats (200 – 250 grams) and female albino rats (150 – 
200 grams) of Wistar strain were used for the study. The rats were housed in 
polypropylene cages and maintained under standard conditions (Temperature range: 65-
75oF and Humidity range: 40-70%). The animals had free access to standard pellet diet 
(Amrut Laboratory Animal Feed, Nav Maharashtra House, Pune, Maharashtra) and water 
utilizing aquaguard. Study was conducted after obtaining Institutional Animal Ethical 
Committee clearance (Proposal No. 16-17/PHARMA/CRIS, 2007). 
 
Drugs and chemicals: 
 
 
The following chemicals were used for the study. Carbon tetrachloride (Merck 
Specialist Private Ltd., Mumbai), Serum enzyme (SGOT, SGPT, ALP and Bilirubin) and 
serum total protein, albumin and globulin estimation kit (Bayer Diagnostics Ltd., 
Mumbai). 
                                                                                                                                                                              
ACUTE TOXICITY STUDY: 
 
The acute toxicity study was carried out using ‘Acute Toxic Class method’ as per 
OECD Guidelines 423. Healthy albino mice of either sex were selected and grouped in to 
six each (Three males and three females). The animals were deprived of diet for four 
hours and water was given ad libitum. The drugs were suspended in honey and 
administered @ 2000 mg/kg body weight orally. Another group of six animals received 
vehicle honey only, which served as untreated control. The animals were observed for         
24 hrs after administration for mortality and thereafter animals were kept under 
observation for 14 days. 
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Drug profile: 
            Route of administration : Enteral 
 Dose level   : 2000 mg/kg  
 Human dose of trial drug : 130 mg twice a day 
 Calculation of animal dose : 60.0 mg/kg 
 Frequency of administration: Once 
 
The animals were observed for the following gross observations: 
  
 Effect on Central Nervous system :   
a) Stimulation 
b) Depression 
 Effect on Respiration   :  
a) Stimulation 
b) Depression 
c) Respiratory failure 
 Effect on Locomotor system  : 
a) Increase in motor activity 
b) Reduction in motor activity 
 Effect on skin colour   : 
a) Blanching 
b) Cyanosis 
c) Vasodilation 
 
Effect on excretions   : 
a) Salivation 
b) Lacrimation 
c) Urination 
Other effects like    : 
a) Piloerection 
b) Tonic and clonic convulsions 
c) Opisthotonus 
d) Ataxia 
e) Body temperature 
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Induction of hepatotoxicity and drug feeding schedule: 
 
 
CCl4 induced liver damage: 
All the animals (30) were weighed and randomly divided into five groups 
comprising of six rats (3 Male + 3 Female) in each. The experimental protocol for CC14 
induced hepatotoxicity is cited in Table 9. The liver damage was induced by 
subcutaneous injection of CC14 in olive oil (1:1) @ 1 ml/kg once on 13th day in Groups 
II, III, IV and V. Group I and V were kept as normal (Honey) and toxic control group, 
respectively. On the other hand, Group II, III and IV were treated with Vediannabedhi 
Chendhooram @ 23.4 mg/kg, Vediannabedhi Chendhooram @ 50 mg/kg and Silymarin 
@ 100 mg/kg orally, respectively. The dose of the drug was calculated on the basis of 
results from acute toxicity studies (1/10th of the maximum tolerated dose). Blood samples 
were collected through retro orbital sinus of all the animals 48 hrs after CC14 
administration. The blood samples were estimated for biochemical parameters such as 
SGOT, SGPT, ALP, Bilirubin, Total protein, Albumin and Globulin. After blood 
collection all the animals were weighed and euthanized under ether anesthesia. All rats 
were subjected for gross lesion on liver and the liver were collected, weighed and 
preserved in neutral buffered 10% (V/V) formalin for histopathology. These were 
processed for paraffin embedding using ethyl alcohol as dehydrant and xylene as clearing 
agent. Paraffin sections of liver, about 4-5 µm thickness, were stained with haematoxylin 
and eosin. These sections were examined for histopathological changes and the cellular 
alterations were scored as described by Hegde et al. (1982).52   
Statistical Analysis: 
The data collected were subjected statistical analysis using unpaired                           
t-test (P.S.S.Sundar Rao, J.Richard). The statistical significance of difference was taken 
as P < 0.05. 
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Table 9 
 
 
 
Experimental protocol for CCl4 induced hepatotoxicity 
 
 
 
Group  
 
Drug Treatment Route and Dose 
(mg/kg) 
Duration 
(Days ) 
Withdrawal of 
Blood and liver 
Purpose 
1. Honey  
 
1 ml /animal p.o 1st – 14th 15th Control 
2. CCl4 + 
Vediannabedhi 
Chendhooram 
1 ml / kg. s.c 
23.4 mg / kg. p.o 
13th 
1st  – 14th 
 
15th 
 
Protective 
effect 
3. CCl4 + 
Vediannabedhi 
Chendhooram 
1 ml / kg. s.c 
50 mg / kg. p.o 
13th 
1st – 14th 
 
15th 
 
Protective 
effect 
4. CCl4 +  
Silymarin  
 1 ml / kg. s.c 
100 mg / kg 
p.o  
13th 
1st – 14th 
 
15th 
 
Standard  
5. 
 
CCl4 1 ml / kg. s.c 13th  15th  Induce 
liver 
damage 
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RESULTS AND OBSERVATIONS 
 
Results of biochemical analysis of Vedi Annabedhi Chendhooram 
 
Table 10 
 
Physical properties: 
 
S.NO                         Parameters      Results (%) 
    
   1. 
 
   2. 
 
   3. 
 
   4. 
 
   5. 
    
   6.  
 
Loss of drying at 105˚C   
         
       Ash value 
 
       Water soluble 
 
       Alkalinity as CaCo3 in water soluble ash 
 
       Acid insoluble ash  
 
       PH at 10% aqueous solution   
 
 
       0.71 
 
       72.0 
 
       24.05 
 
 0.15 
 
       20.0 
 
       1.78         
 
Table 11 
 
Qualitative analysis: 
 
 
 
  
Table 12 
 
Quantitative analysis: 
 
 
S.NO          Parameters          Results  
 
   1.  
 
   2. 
  
          Manganese 
 
          Selenium 
 
 
         0.16% 
 
         6.2 mg/kg 
 
S.NO        Parameters          Results 
 
   1. 
 
Calcium 
 
         Present 
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RESULTS OF XRF STUDY 
 
XRF studies on the drug Vediannabedhi Chendhooram reveals the presence of 
Sulfur, Manganese and Potassium. 
  
 
RESULTS OF XRD STUDY 
 
                  In this study, the graph of the sample of Vediannabedhi Chendhooram was 
matched with standard graph of Ferric oxide and Ferrous oxide.   
 
 
 
RESULTS OF PHARMACOLOGICAL STUDIES 
 
 
A) ACUTE TOXICITY STUDY: 
  
 No mortality, morbidity, weight loss or abnormal behavior was recorded after 
single exposure of the test compound @ 2000 mg/kg body weight during 14 days 
experimental period in Swiss Albino mice. This indicates that Vediannabedhi 
Chendhooram is safe up to a dose of 2000 mg/kg body weight. 
 
B) BIOCHEMICAL PROFILES OF TRANSAMINASES: 
 
In the present study SGOT, SGPT, ALP, Bilirubin, Total protein, Albumin and 
Globulin values were estimated by using a semi autoanalyser. Mean levels of SGOT, 
SGPT, ALP, Bilirubin, Total protein, Albumin and Globulin are presented in Table 13 
and 14. Both the transaminases are referred to as “Makers of Cell Injury” (Loeb, 1982) 
and are excellent indicators of early hepatic lesion since they are the first to leak out from 
the cell in case of an injury. Values of transaminases do not vary significantly with 
respect to age and sex in rat (Ringler and Debich, 1979). 
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 In the present study the mean SGOT, SGPT, ALP, Bilirubin, Total protein, 
Albumin and Globulin value of each group of rats at the 15th day of the experiment is 
compared with the values of hepatotoxic control group. 
  
 
In this study the rats included in Group V showed significant increase (P < 0.05) 
in ALP values compared to the values of Group I. In the group II (Vediannabedhi 
Chendhooram @ 23.4 mg/kg) there was significant reduction in ALP levels as compared 
to that of Group V (P < 0.02). In the group III (Vediannabedhi Chendhooram @ 50 
mg/kg) there was non significant reduction in ALP levels as compared to that of Group 
V. In the group IV (Silymarin @ 100mg/kg) there was significant reduction in ALP levels 
as compared to that of Group V (P < 0.01). 
  
The rats in Group V showed significant increase (P < 0.01) in SGPT values 
compared to the values of Group I. In the Group III there was non significant reduction in 
SGPT levels as compared to that of Group V. whereas, in the Group II and IV there was 
significant reduction in SGPT levels as compared to that of Group V (P < 0.01). The 
SGOT levels showed non significant change in all the group of rats. 
  
 The rats in Group V showed significant decrease (P < 0.001) in Total protein 
levels compared to the values of Group I. In the Group II and III there was significant 
increase in Total protein levels as compared to that of Group V (P < 0.05). While, in the 
Group IV there was significant increase in Total protein levels as compared to that of 
Group V (P < 0.001). There was increase in serum globulin levels in treatment groups II, 
III and IV but they are statistically non significant. There was reduction in serum globulin 
levels in toxic group (Group V) but it was statistically non significant. 
 
It obviously indicates that Vediannabedhi Chendhooram plays an important role 
in preventing and the liver toxicity produced due to carbon tetrachloride administration in 
rats. 
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Table 13 
 
Effect of Vediannabedhi Chendhooram in CCl4 induced liver damage 
 
Group Percent change 
in body weight 
Alkaline Phosphatase  
(ALP) 
Aspartate Amino 
Transferase (SGOT) 
Alanine Amino 
Transferase (SGPT) 
I 13.33 ± 3.30 174.66 ± 20.35b 190.66 ±15.03NS 61 ± 2.42a  
II 05 .00 ± 3.42 182.33 ± 14.37c 171.33 ± 10.6NS 62.33 ± 4.33a 
III 06.67 ± 3.33 220.83 ± 28.10NS 219.5 ± 29.19NS 77.5 ± 8.52 
IV 13.33 ± 4.21 186.00 ± 23.12a 226 ± 9.55NS 66.5 ± 6.82 b 
V -06.67 ± 3.3 231.16 ± 07.26 217.5 ± 25.73NS  88.67 ± 6.58  
 
Values are mean ± S.E, Unpaired t – test.  N = 6 in each groups. 
 
          a P < 0.01 Vs Toxic 
          b P <  0.05 Vs Toxic 
          c P < 0.02 Vs Toxic 
 
 
 
 
Table 14 
 
Effect of Vediannabedhi Chendhooram in serum proteins and bilirubin levels 
 
Group  Total protein Albumin Globulin A / G ratio Bilirubin 
I 8.1 ± 0.2*** 3.1 ± 0.13 4.36 ± 1.18 0.63 ±0.07 0.43 ±0.02 
II 7.38 ± 0.2* 3.45 ± 0.12 3.93 ± 0.73 0.90 ± 0.18 0.36 ± 0.04 
III 7.43 ± 0.2* 3.13 ± 0.17 4.3 ± 0.25 0.75 ± 0.08 0.42 ± 0.10 
IV 8.45 ± 0.18*** 2.9 ± 0.08 5.53 ± 0.24 0.53 ± 0.04  0.29 ± 0.02
V 6.63 ± 0.23 3.08 ± 0.08 3.85 ± 0.23 0.73 ± 0.02 0.38 ± 0.05 
 
Values are mean ± S.E, Unpaired t – test.  N = 6 in each groups. 
 
          *** P < 0.001 Vs Toxic 
             * P < 0.05 Vs Toxic 
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EFFECT OF VABC ON ALP LEVELS 
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EFFECT OF VABC ON SGPT LEVELS 
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EFFECT OF VABC ON SGOT LEVELS 
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EFFECT OF VABC ON SERUM BILIRUBIN LEVEL 
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EFFECT OF VABC ON SERUM PROTEIN LEVELS 
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C) HISTOPATHOLOGICAL STUDY OF HEPATIC SECTIONS 
 
 The present study was primarily aimed at carbon tetrachloride induced liver 
damage in the rats. Vacuolar, moderate and diffuse degeneration of hepatocytes, changes 
were observed in the livers of rats and no mortality was seen in experimental animals, 
during the experiment. 
 In the sections of liver obtained on 15th day of the experiment, there were no 
changes observed in normal control (Group I) whereas, mild degree of vacuolar 
degeneration of hepatocytes was observed in Group II (Fig.2) and IV (Fig.3). The 
severity of lesion increased (Moderate to Diffuse vacuolar degeneration) in                     
Group III (Fig. 4) followed by Group V (Figure 5). 
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Fig. 1 Photomicrograph of rat liver in Group I (Normal Control showing normal 
section). 
 
(H & E 320x) 
 
Fig. 2 Photomicrograph of rat liver in Group II (Vediannabedhi Chendhooram            
@ 23.4 mg/kg). Section showing Mild vacuolar degeneration 
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(H & E 320x) 
Fig. 3 Photomicrograph of rat liver in Group III (Vediannabedhi Chendhooram            
@ 50 mg/kg). Section showing Moderate vacuolar degeneration 
 
 
(H & E 320x) 
 
Fig. 4 Photomicrograph of rat liver in Group IV (Silymarin @ 100 mg/kg).  
Section showing Mild vacuolar degeneration 
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(H & E 320x) 
 
 
 
 
Fig. 5 Photomicrograph of rat liver in Group V (Hepatotoxic control). 
Section showing Diffuse vacuolar degeneration 
 
 
 
 
(H & E 320x) 
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DISCUSSION 
  
The siddha drug Vediannabedhi Chendhooram was selected to find its efficacy in 
the management of Kaamalai. 
 
The literature evidences about the drug strongly supports the hepatoprotective 
action of the drug Vediannabedhi Chendhooram. 
 
 Biochemical analysis of the drug reveals the presence of minerals namely 
Selenium, Manganese, Calcium and Potassium. 
 
Selenium: 
  
 Selenium along with VitaminE prevents the development of hepatic necrosis and 
muscular dystrophy. Selenium binds with certain heavy metals like Mercury, Cadmium 
and protects the body from toxic effects. Thus it helps in detoxification function of liver. 
 Selenium prevents lipid peroxidation and protects the cells against the free 
radicals including super oxide. Selenium involved in the maintenance of structural 
integrity of biological membranes. Selenium as selenocysteine is an essential component 
of enzymes Glutathione peroxidase, which protects the cells against oxidative damage by 
hydro peroxidases. Thus it acts as a potent antioxidant; prevent liver damage by free 
radicals. It also facilitates digestion and absorption of lipids including vitamin E which is 
a potent antioxidant.46 
 
Manganese: 
                   
 Manganese is a micronutrient which is predominantly stored in the bones, liver, 
kidney, and pancreas. It has antioxidant properties and is needed to activate a number of 
enzymes, helps the body to absorb vitamin B1 (thiamine) and vitamin E. Haemoglobin 
synthesis also involves Manganese. Manganese inhibits lipid per oxidation. 
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 Manganese is a component of the antioxidant enzyme manganese superoxide 
dismutase (MnSOD). Antioxidants scavenge damaging particles in the body known as 
free radicals. These particles occur naturally in the body but can damage cell membranes, 
interact with genetic material, and possibly contribute to the aging process as well as the 
development of a number of health conditions and organ damage. Antioxidants such as 
MnSOD can neutralize free radicals and may reduce or even help to prevent some of the 
damages of organs they cause. 
 
Calcium: 
 Calcium plays a role in membrane integrity and permeability of cell. Calcium 
influences the membrane structure and transport of several ions across it.  
 
Potassium: 
 Adequate intracellular concentration of Potassium is necessary for proper 
biosynthesis of proteins by ribosome. Hypokalaemic is one of the indicators of chronic 
liver damage.48 Hence Potassium supplements in patients with liver damage may be 
advisable. 
 
XRF studies on the drug reveals the presence of Sulfur, Manganese and 
Potassium. 
 
Sulfur: 
Sulfur is the main component of aminoacids, Vitamins, Coenzymes and 
mucopolysaccharides such as heparin and Chondroitin sulfate. Transmethylation reaction 
which is an important metabolic function of liver depends on Sulfur containing enzymes. 
Sulfur containing aminoacids are very essential for the structural conformation and 
biological functions of proteins and enzymatic reactions.49 
 Methionine and cystein have protective effect on Glutathione and prevent 
depletion of it during toxic overload. This in turn protects the liver from damaging effects 
of toxic compounds and promotes their elimination. Glutathione is an important 
antioxidant; deficiency is the cause of serious liver dysfunction and damage.46 
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Limonene which is a principal constituent of lemon has protective effect due to 
stronger induction of phase1 and phase 2 detoxification enzymes.46 
 
Pharmacological Studies: 
 
 The pharmacological action of the drug Vediannabedhi Chendhooram was carried 
out in Central Research Institute for Siddha, Arumbakkam,Chennai. 
 Hepatoprotective activity in rat models using Wistar albino rats, carried out in 
Carbon tetra chloride induced liver damage. The study demonstrates liver damage in 
toxic groups, evidenced by elevated serum enzyme levels and histopathological features, 
the protective groups administered with Vediannabedhi Chendhooram @ 23.4 mg/kg  
along with Carbon tetra chloride showed protective effects on liver damage evidenced by 
reduction in serum enzyme levels and histopathological studies. From the biochemical 
analysis and histopathological studies it was observed that Vediannabedhi Chendhooram 
is effective at the rate of 23.4 mg orally in rats as compared to other groups. 
 Further, the hepatoprotective and curative effect of the drug on chronic liver 
damage have to be studied. Its effect on lipid peroxidation in liver and antioxidant 
enzyme status in liver during treatment with Vediannabedhi Chendhooram have to be 
evaluated. 
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Siddha aspect 
 
 According to siddha concept Kaamalai is a condition due to vitiated Azhal 
humour, which disturbs Iyyam also. This results in disturbed function of Viyanan (one 
among the 10 Vayus ) and spread of biliousness in blood and yellowish discoloration of 
the body.  This disease condition affects the regions of Azhal vazhum idam like liver, gall 
bladder, gastrointestinal tract and biliary tree. 
  ÀñÀ¡É À¢ò¾ò¾¢ø §ºòÐÁ¿¡Ê  
                           ÀÃ¢º¢ò¾¡ Äò¾¢ÍÃÁ¢¨ÇôÒ ®¨Ç 
  ¸ñ¸¡Ð ¿ÂÉÁÄ ¿£Õ Áïºû 
                           ¸ÉÅÂ¢Ú ¦À¡ÕÁø Áïºû§¿¡ö ¸ñ§½¡× 
                    ............................................. 
                     
(º¢¸¢îº¡Ãò¿¾£Àõ). 
 
The compound drug prepared using the drugs Annabedhi, Vediuppu and lemon 
juice was indicated for Kaamalai.  
 
Annabedhi has thuvarppu and veppa veeriyam. Thuvarppu suvai normalizes Azhal 
humour. This is mentioned in siddha literatures as,  
 
                     À¢ò¾ Á¾¢¸Ã¢ôÀ¢ý §ÀÍõ ÀÃ¢¸¡Ãõ 
                     Íò¾ò ÐÅ§Ã¡Î ¦º¡øÄ¢É¢ôÒî ºò¾¡Ìõ 
                     ¨¸ôÒî Í¨Å§Â ¸Õ¾Å¾ý Å£Ú 
                     ±öôÀ¨¼Ô ¦ÁýÚ¨Ãò¾¡ Ã¢íÌ. 
 
                       (¸ñÏº¡Á¢Âõ) 
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 Annabedhi is indicated for diseases affecting Azhal humour like GIT disorders, 
Peru vayiru. It also increases the power of digestion and biliary secretion.  
 
 Vediuppu is one of the salts that belong to Theyu pootha kooru. It is indicated for 
diseases in the region where Azhal humour predominates likes kidney, stomach, liver, 
spleen etc and also for Peru vayiru (which is a condition due to the derangement of Azhal 
and Iyyam and is one of the complications of hepatic diseases). 
 
 Vediuppu has diuretic action also which accounts for symptomatic relief in 
chronic case of hepatic damage with fluid retention in the body. 
 
 Lemon juice used for grinding the above drugs belongs to veppa veeriyam and has 
sour taste. It is indicated for disease due to exaggerated Azhal humour like vomiting, 
giddiness, biliousness and psychiatric problems.  
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SUMMARY AND CONCLUSION 
 
 
 The drug Vediannabedhi Chendhooram has selected for the study to evaluate its 
efficacy in the management of Kaamalai. 
 
 The literature collection describes the Hepatoprotective activity of the drug 
Vediannabedhi Chendhooram. 
  
 The chemical analysis of the drug Vediannabedhi Chendhooram reveals            
the presence of minerals namely Selenium, Manganese, Sulfur, Iron, Calcium and 
Potassium. 
 
 Pharmacological studies showed that the drug has significant hepatoprotective 
activity at the dose of 23.4 mg and no significant adverse effects. 
 
The drug is more effective in the therapeutic dose determined by siddhars (Oru 
kuntri edai 150 mg) and less effective in higher doses. Hence it can be concluded that the 
correct dose regimen, anupanam and exact method of preparation of drug only give 
expecting results and more success to siddha medicines.   
  
 Each and every study of the drug Vediannabedhi Chendhooram gives a new hope 
in the management of Kaamalai. 
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